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The first synthesis of the individual stereoisomers of malathion [S-(1,2dicarboethoxyethyl)

0,0-dimethyl

phosphorodithioate],

malaoxon

[S-(1,2-

dicarboethoxyethyl) 0,0-dimethyl phosphorothiolate], and isomalathion [S-( 1,2dicarboethoxyethyl) O,S-dimethyl phosphorodithiolate] has been accomplished.
Malathion enantiomers were prepared from malic acid enantiomers in three steps.
Malaoxon enantiomers were prepared from the corresponding malathion
enantiomers via oxidative desulfuration with MMPP. Isomalathion stereoisomers
were prepared by two separate paths employing fractional crystallization of alkaloid
phosphorothioic acid salts.
No in vitro AChE inhibition data could be obtained for the malathion
enantiomers owing to limited solubility. (R)-malathion was shown to be a more
potent insecticide against Drosophila Melanogaster.

The bimolecular reaction

constant (ki), dissociation constant (K0 ), and phosphorylation constant (kp) for the
inhibition of rat brain acetylcholinesterase by malaoxon enantiomers and for the

inhibition of rat brain acetylcholinesterase and electric eel acetylcholinesterase by
isomalathion enantiomers were determined. (R)-Malaoxon was an 8-fold stronger
inhibitor than (S)-malaoxon. Isomalathion stereoisomers with the R configuration
at phosphorus

were 4.3

to

8.8-fold stronger inhibitors

of rat brain

acetylcholinesterase but 3.4 to 5.8-fold weaker inhibitors of electric eel
acetylcholinesterase than the stereoisomers with the S configuration at phosphorus.
Spontaneous (k0 ) and oxime-mediated (k0 xime) reactivation rate constants Wt(re
obtained for rat brain acetylcholinesterase inhibited by the isomalathion
stereoisomers. Reactivation rate constants for acetylcholinesterase inhibited by the
R at phosphorus isomalathion stereoisomers were comparable to those of

acetylcholinesterase inhibited by (S)-isoparathion methyl, which supports a common
phosphorylation mechanism, namely, formation of identical O,S-dimethyl
phosphorylated enzymes.

Rat brain acetylcholinesterase inhibited by the S at

phosphorus isomalathion stereoisomers was refractory to reactivation suggesting an
alternate mechanism of inhibition, i.e., the loss of the thiomethyl ligand. Several
mechanisms are proposed to account for this nonreactivation observed with the S
at phosphorus isomalathion stereoisomers. Rate constants for non-reactivatability
(kNR) were determined for rat brain acetylcholinesterase inhibited by isoparathion

methyl enantiomers as a model for acetylcholinesterase inhibitors resulting in an
asymmetric

O,S-dimethyl

phosphorothiolated

enzyme.

Rat

brain

acetylcholinesterase inhibited by (R)-isoparathion methyl underwent a timedependent decrease of reactivatability twice that of (S)-isoparathion.
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CHAPTER 1
INTRODUCTION

"The implications of pesticide use can not be understood without a
basic understanding of pesticide chemicals and an appreciation of
their benefits and risks. Ultimately, it will be up to the public - the
consumers - to determine the limits of pesticide use. A better
understanding of the science behind such an issue gives us a
perspective that aids us in participating responsibly and fully in
public policy decision-making (Parr, 1987)."

Pesticide Utility and Societal Impact
One of the primary responsibilities of any society is to support its
population with an adequate supply of food. In that effort, it is estimated that
nearly half of all agricultural produce is destroyed by pests, mostly during storage
(Perutz, 1991). Thirty percent of the potential crop, livestock, and timber yield
is believed to be lost annually to insects or other pests (Furtick, 1976; Cagliotti,
1983). Grain losses prior to harvest in developing countries of the Near East are
approximately 23% with the largest losses in the production of cereal crops,
especially rice (Hayes, 1991).
Advances in pesticide design over the past fifty years have significantly
contributed toward increased crop yield by diminishing the population of
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threatening organisms. In addition, some insecticides have been instrumental in
the reduction of malaria and other insect-borne diseases in humans (Cagliotti,
1983). In addition to influencing crop yields, insecticide usage also impacts on
the economy. It is estimated that without the use of pesticides, prices for fruits
and vegetables would increase 50 to 100% in first world countries (Schuhman,
1976).

Pesticide application for food consumption necessitates significant

production; approximately 3 billion pounds of pesticides are produced in the U.S.
annually, one third of which are insecticides.

In addition, U.S. consumers

purchase roughly 25% of all insecticides resulting in annual sales of nearly 900
million dollars (Welling, 1988).

Hazards of Pesticide Use
According to the World Health Organization (WHO), it is estimated that
3 million acute pesticide poisonings occur annually leading to 250,000 fatalities,
of which 99% occur in developing countries (Stephens, 1991; Rosenstock, 1991 ).
In Sri Lanka, nearly 13,000 people are admitted annually to hospitals for pesticide
poisoning that result in approximately 1000 fatalities. It is estimated that 40,000
farmworkers of third world countries die each year as a result of pesticide
intoxication. Generally, these agricultural workers are poisoned because either
they cannot read, understand, or implement safety instructions, or the instructions
themselves are inadequate (Perutz, 1991).

Approximately 300,000 pesticide
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poisonings are reported in the United States annually (Rosenstock, 1991). It is
also believed that many deaths due to pesticides are unreported (Forget, 1991).
Over-exposure to insecticides is greatest for those who are directly involved
in their application, including mixing concentrates and loading aircraft for aerial
pesticide application (Barnes, 1976). Protective clothing for U.S. agricultural
workers has been assumed to be adequate defense against exposure. In 197 4,
protective clothing was documented as "at least a hat or other suitable head
covering, a long-sleeved shirt and long-legged trousers, or a coverall type
garment, shoes and socks." Recent revisions to these recommendations by the
EPA and USDA include: a liquid-proof raincoat or apron, trousers outside of
boots, unlined neoprene gloves, wide-brimmed waterproof hats, unlined neoprene
boots, and goggles or face shields (Stone, 1988). Other steps have been taken to
prevent the occurrence of acute poisonings such as medical monitoring of
agricultural workers.

One such attempt has been made by California's

Department of Health Services in which periodic monitoring for exposure to
agrichemicals is conducted (Ames, 1989).
Despite increased protective measures for U.S. agrichemical workers,
pesticide poisonings remain a continuing concern in developing countries. A
significant number of poisonings seem to result from "lack of knowledge, unsafe
attitudes, and dangerous practices (Forget, 1991)." A further problem relates to
the state of the technology available to small farmers such as "faulty sprayers,
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lack of protective equipment adapted to tropical conditions, and non-existent firstaid provisions (Forget, 1991)."

It has been suggested that one of the most

important factors contributing to pesticide poisonings in developing countries is
a lack of information (Forget, 1991).
Because pesticides are toxic and yet help support growing populations
through crop protection, several conflicts in usage have arisen. Thus, in order to
justify the production and implementation of such compounds, a number of issues
must be considered including: the human health risks from direct exposure and
food residues, worker occupational hazards, and possible contamination of
drinking water (Zilberman, 1991).

Organophosphorus COP) Insecticides
Organophosphorus (OP) compounds are members of the insecticide arsenal
that includes carbamates, chlorinated hydrocarbons, and pyrethroids. To date,
more than 50,000 organophosphorus (OP) compounds have been synthesized and
evaluated for their insecticidal potential (Gutmann, 1990). Among these, several
OP' s have been specifically stockpiled for military use as genocide-based
neurotoxic agents (nerve gas) including sarin 1, soman 2, and tabun 3 (Figure 1;
Caglioti, 1983).
The synthesis of TEPP (tetraethyl pyrophosphate 4, Figure 1) in 1854 most
likely spawned investigations of toxic OP compounds (Eto, 1974). Their
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1:sarin

3: tabun

2: soman

4:

TEPP

5:DFP

Figure 1. Neurotoxic Organophosphorus Compounds.

development was furthered by both Schrader (Germany) and Saunders (England)
during WWII while searching for chemical warfare agents such as diisopropyl
phosphonofluoridate (DPF 5; Figure 1) (Eto, 1974). As an outgrowth of these
studies, Schrader and coworkers identified several OP compounds that exhibited
contact insecticidal activity.

The first practical insecticide, Bladen, which

contained the highly toxic compound TEPP, was developed by Schrader and
coworkers in 1941 and was subsequently marketed in 1944 (Eto, 1974). Since
the 1940's, thousands of new OP insecticides have been developed.
Because of their relatively short-lived environmental lifetime, OP's have
replaced the environmentally persistent, chlorinated hydrocarbons such as DDT;
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C02C2H5

6: malathion

R=CH 3, X=

7: parathion methyl
8: parathion
9: chlorpyrifos

s~C02 C 2 H 5

R=CH3, X= o-Q-No2

R=CH3CH2 , X= o-O-N02
R=CH3CH2 , X= O~Nj(CI

Cl~CI

Figure 2. Common OP Insecticides.

its use was banned in the United States during the 1970's due to notable retention
in body tissue and biomagnification (Matolcsy, 1988; Mahieu, 1990; Stephens,
1991). It is estimated that 31 to 48 billion pounds of the four most popular
organophosphate insecticides, malathion 6, parathion methyl 7, parathion 8, and
chlorpyrifos 9 (Figure 2) are used each year in the United States (Stephens, 1991).

Structure and Reactivity of OP Insecticides
In order to discuss organophosphorus (OP) insecticides in detail, a brief
review of nomenclature, structure, and chemical reactivity is necessary. Some
general structures of OP compounds that will be discussed in this dissertation are
shown in Figure 3. For insecticidal activity, one of the ligands attached to the
phosphorus atom is generally required to be a good leaving group. This aspect
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Figure 3. General Structure of OP Compounds.

of OP reactivity and its relationship to biological activity will be discussed in
Section 1.8.
Most OP insecticides belong to the phosphorothionate class (P=S). Two
main features of OP's that influence their chemical reactivity are: the 7t-atom
linkage, and the a-ligand connectivity. Two examples will serve to illustrate
these points.

As opposed to the sulfur of the P=S linkage, the more

electronegative oxygen atom of the P=O bond imparts a greater electrophilicity
at the phosphorus atom making it more susceptible to nucleophilic attack and
hydrolysis (Matolcsy, 1988; Fest, 1973; Van Wazer, 1958). This feature is

8

s

0

0

II

II

II

¢

Eto--/'o
EtO

¢

Eto--/'o
EtO

I~

I~

~

~

N02

N02

8: parathion

10:

mo

Ets--/'o

paraoxon

I~

N02
11:

isoparathion
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exemplified by the 9-fold difference in the hydrolytic t 1n (pH = 8) values for
parathion 8 (203,000 h) and paraoxon 10 (22,200 h) (Figure 4, O'Brien, 1967).
The thiolate (P-S-R) linkage also affects the reactivity of OP's. Phosphorothiolate
esters are more chemically reactive than their phosphate analogues because the
sulfur atom imparts greater polarizability and decreased p7t-d7t contribution to the
P-S bond due to the less efficient orbital overlap (Eto, 1974). The more rapid
hydrolysis (470-fold) of isoparathion 11 compared to that of paraoxon 10
illustrates the importance of the thiolate sigma-bond contribution toward the
reactivity of OP's (Heath, 1961).

Thiono-Thiolo Rearrangement
Dialky1 phosphorothionates are prone to chemical, thermal, and to a lesser
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phosphorothionate

phosphorothiolate

Figure 5. Thiono-Thiolo Rearrangement.

extent, photochemical induced isomerization to the corresponding S-alkyl
phosphorothiolates (Figure 5). This transformation is known as the thiono-thiolo
rearrangement.

The rearrangement may be promoted by reaction of a

phosphorothionate with an alkyl iodide to form the S-alkyl isomeride by first
alkylation of the thionate followed by dealkylation (Figure 6) (Eto, 1974).
Self-isomerization, or bimolecular isomerization, occurs at elevated
temperatures (80-180 °C) where one phosphorothionate is dealkylated by another
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Figure 6. Alkyl Iodide Catalysis of the Thiono-Thiolo Rearrangement.
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to form an ambident ion pair that realkylates at the more nucleophilic sulfur atom
(Figure 7) (Fest, 1973; Eto, 1974). This isomerization occurs fastest when the
alkyl group transferred is methyl (Eto, 1974). Isomerization also may occur at
room temperature over a long period of time when phosphorothionates are stored
in polar aprotic solvents (Eto, 1974, Matolcsy, 1988).
Unfortunately, thiono-thiolo transformation may transpire during the
manufacture or storage of phosphorothionate insecticides. Indeed, malathion (6)
formulations have been found to contain as much as a 10% contamination of the
thiolo

isomeride,

isomalathion

12

(Figure

5;

R1

=

CH 3 ,

R2

=

SCH(C02Et)CH2C02Et), and it has been shown that approximately 90% of
malathion 6 was isomerized to isomalathion 12 at 150 °C (Metcalf, 1953). In the
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same study, parathion (Figure 5, R 1 =Et, R 2 = 0-p-Ph-N0 2 ) was isomerized (150
0

c,

24 h) to the S-ethyl thiolate in 80% yield while 90% of parathion methyl

(Figure 5, R 1 = CH 3 , R 2 = O-Ph-N0 2) was isomerized under the same conditions.

Mode of Action of OP' s - General Aspects
Regardless of the effectiveness of OP's in insect control, numerous
accidental OP poisonings of humans occur every year.

The toxicity of

organophosphates to mammals and insects is primarily due to their ability to
inactivate the enzyme acetylcholinesterase (AChE). AChE is found in both the
central and peripheral nervous system, the primary role of which is to catalyze the
hydrolysis of the neurotransmitter acetylcholine (ACh, 13; Figure 8) (Quinn,
1987). The rate at which AChE facilitates the hydrolysis of AChE 13 is on the
order of 105 molecules per minute.
During the transmission of a nerve signal, ACh is released from
presynaptic vesicles and diffuses across the synapse to bind at ACh receptors of
the post-synaptic membrane, thus, completing the signal. AChE rapidly removes
surplus ACh from the synapse to either terminate the neural transmission at
cholinergic synapses or maintain the correct titer of ACh during enervation
(Figure 9).
When an OP inactivates AChE, the result is an accumulation of ACh in the
neural synapses and neuromuscular junctions promoting continued and
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Figure 8. AChE Mediated Hydrolysis of ACh.

uncontrolled neural transmission.

Inactivation of AChE is manifested in

stimulation of the nicotinic and muscarinic receptors of autonomic organs and
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Figure 9. The Role of AChE in Neural Transmission.

13

skeletal muscles as well as stimulation of cholinergic receptors (predominantly
muscarinic) of the CNS. General effects following OP intoxication include those
outlined in Table 1(Goodman,1985). In severe acute poisonings, paralysis of the
respiratory muscles may occur and result in death (Mahieu, 1990).

Table 1. Effects of Severe OP Intoxication on Mammals.
Muscarinic Effects
extreme salivation
involuntary defecation
and urination
sweating
lacrimation
bradycardia
hypotension

Nicotinic Effects
generalized weakness
involuntary twitching
fasciculations
paralysis

CNS Effects
confusion
ataxia
slurred speech
loss of reflexes
convulsions
coma
respiratory
paralysis

The AChE Active Site
There are three important features of the active site of AChE: (1) the ester
binding locus that contains a nucleophilic serine residue involved in the hydrolytic
mechanism of AChE, (2) the anionic domain situated approximately 4.7

A from

the serine, which is responsible for binding the ACh quaternary ammonium group,
and (3) a hydrophobic region that binds aryl-containing substrates (Figure 10;
Quinn 1987).
A recent X-ray crystal structure of AChE from Torpedo californica
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Figure 10. Salient Features of the AChE Active Site.

revealed that the active site was positioned at the bottom of a deep (approximately
20

A)

and narrow gorge penetrating halfway into the enzyme (Sussman, 1991;

Maelicke, 1991). In addition, structural homology to other hydrolases such as
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wheat serine carboxypeptidase-II were identified.

Mechanism and Kinetics of AChE Inactivation by OP' s
OP' s inactivate AChE by phosphorylation of the active site serine hydroxyl
where one ligand (X) about phosphorus is displaced (Eqn. 1). The result is a
covalently modified enzyme absent of any hydrolytic activity. The first step in
this AChE inactivation involves the reversible formation of an enzyme-inhibitor
complex and is represented by the dissociation constant, K0 (Main, 1964). K0 is
generally considered a measure of the OP-inhibitor's affinity for the enzyme's
active site (Fukuto, 1990). The second step of inhibition results in the irreversible
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phosphorylation of AChE by an OP inhibitor.

Covalent modification of the

serinehydroxyl of the enzyme is responsible for the ultimate loss in the enzyme's
activity (i.e. the inability to hydrolyze ACh). The phosphorylation rate constant,
~'

is considered a quantification of the reactivity of the OP inhibitor or the

enzyme-inhibitor complex (Main, 1964, Fukuto, 1990).
A more useful parameter that describes the overall rate of inhibition is the
bimolecular reaction (or rate) constant,
function of both K0 and

~ (~

=

~0)

~

(Debord, 1986). This parameter is a

and a measure of the potency of an OP

inhibitor. Bimolecular reaction constants (as well as K0 and

~)

for OP's are

determined experimentally by the following equation:

ll[i]

= (~t I ~lnv)ki -

l!Kv

(2)

where [i] is concentration of the OP inhibitor, llt is the time that the AChE is
reacted with the inhibitor, vis the activity of AChE, and k; = k/Kv (Main, 1964).
Although the method described in Eqn. 2 provides useful data, most
inhibitory potencies (ki) are reported using the following equation:

Afnv =

[i]ki~t

(3)
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where the time dependent loss of enzyme activity is monitored in the presence of
a single concentration of the OP (Aldridge, 1950). Experimentally, it is more
convenient to utilize Eqn. 3 than Eqn. 2 as there is one less variable. However,
Eqn. 3 ignores the reversible step of the inhibition and is most valid when the K0
is several-fold greater than the inhibitor concentration (Main, 1964). In addition,
the resultant ~ values obtained using this latter approach have been shown to vary
inversely with inhibitor concentration, [i] (Main, 1964).

Therefore, this

determination may not be reliable for comparing the inhibitory potency of
inhibitors if the concentrations used for the evaluation differ significantly.
The rate and extent of the AChE inhibition depends upon the nature of the
OP-inhibitor's structure, which influences phosphorylation through the electronic
environment about the phosphorus. For example, phosphates are better inhibitors
than thionates. For a series of diethylaryl-substituted phenylphosphates (Figure
11), those containing more electron-withdrawing substituents were found to be
more potent inhibitors of AChE. For example, the concentration of diethyl-pnitrophenylphosphate (Figure 11, X = NOi) needed to affect 50% inhibition of
AChE was 10,000-fold less than diethyl-p-methylphenylphosphate (Figure 11, X

= CH 3)

(Eto, 1974).

When steric factors are considered, the rate of inhibition decreased with
increasing bulkiness of the ligands that remained attached following inhibition of
AChE; methoxy containing inhibitors reacted most rapidly followed by those

18

0

II

0

Eto--r'-.....0
EtO I~

~

x

Figure 11. Diethyl Phenyl Phosphates.

bearing ethoxy, n-propoxy, and isopropoxy ligands (Gallo, 1991). Further,
a rapid decrease in inhibitory activity was observed when the alkyl chain length
of ethyl p-nitrophenyl alkylphosphonates was increased from 3 to 6 carbon atoms
(Fukuto, 1990; Wallace and Herzberg, 1988).

Spontaneous Reactivation of AChE Inhibited by OP' s
Following phosphorylation of AChE, the enzyme may spontaneously
recover its activity as water (H20/0H-) facilitates the hydrolysis of the phosphoserine linkage (Equation 4). Reactivation of AChE is analogous to the second
step of the AChE-catalyzed hydrolysis of ACh (i.e., the hydrolysis of the acetoxy
moiety). However, the rate of spontaneous reactivation (ko) of AChE inhibited
by an OP is far less (>107-fold than the turnover rate for the natural substrate,
ACh) (Eto, 1974).
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OH

spontaneous
reactivation

ko

vvL

+

(4)

AChE

EnrOH + HOP(O)R1 R2

Spontaneous reactivation is dependent upon not only the source of the
enzyme, but upon pH, ionic strength, and temperature (Lieske, 1980; Lanks and
Seleznizk, 1981; Lieske, 1990). The rate at which AChE recovers from inhibition
also depends upon the nature of the appended phosphoryl group (Lieske, 1980;
Clothier, 1981; Langenberg, 1988; Wallace and Herzberg, 1988, Lotti, 1991).
AChE reactivates most rapidly when phosphorylated by an inhibitor with less
bulky ligands (R1 and R2, Eqn. 4). For example, dimethoxy phosphorylated
AChE (R1 =R2 = -OCH 3) reactivates at rates 15 and 30-fold faster than diethoxy
and di-n-propoxy phosphorylated AChE, respectively (Gallo, 1991).

AChE

possessing a di-isopropoxy phosphate moiety is essentially recalcitrant toward
reactivation (Eto, 1974).

Oxime-Induced Reactivation of AChE Inhibited by OP's
Therapeutic treatment following an OP poisoning episode usually involves
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the administration of atropine (a cholinergic antagonist) in order to antagonize the
effect of accumulated ACh (Goodman, 1985; Lotti, 1991). Additionally, it is also
desirable to expedite the recovery process by regenerating AChE activity via
facilitated displacement of the phosphoryl moiety. To this end, many therapeutic
agents have been designed.
Several investigations into the design of reactivating mediators show that
the nucleophilic oxime moiety is an essential feature (Miller, 1984; Bedford,
1986). Further, most potent reactivators possess a positively charged quaternary
nitrogen atom that directs the reactivating species to the anionic locus of AChE
in a favorable position to facilitate nucleophilic displacement of the phosphate
from the enzyme (Gallo, 1991). The most commonly employed oxime used
therapeutically for OP-poisoning in humans is 2-pyridine aldoxime (2-PAM, 16)
shown reacting with phosphorylated AChE in Eqn. 5 (Lotti, 1991).

OH

+

2-PAM

OH

koxime

~
AChE

(5)
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As with spontaneous reactivation, oxime-mediated displacement also is
dependent upon the enzyme source (Lotti, 1991) in addition to the ligands
attached to phosphorus. Phosphorylated AChE possessing less bulky ligands
(such as dimethoxy) readily reactivate in the presence of oximes. For example,
the reactivation rate constant, koxime• for dimethylphosphorylated (R 1 =R2 =OMe)
AChE is 60-fold greater than the diethyl analog (Clothier, 1981). Diethyl
phosphorylated AChE undergoes oxime-promoted reactivation considerably faster
than diisopropyl phosphorylated AChE (Eto, 1974).

Aging and Non-Reactivation of AChE Inhibited by OP's
AChE inhibited by an OP ester may become increasingly reluctant to
reactivate as the interval of time prior to oxime administration increases. One
process which explains this phenomena has been described as "aging." Aging
(kA0 ) of OP-inhibited AChE is attributed to either the dealkylation or hydrolysis
of one of the two remaining phosphate ester moieties (Eqn. 6) (Eto, 1974). As
a result, the charged species formed is then unsuited for the approach of

(6)
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nucleophiles such as water or oximes (Gallo, 1991). An alternative explanation
for time-dependent reluctance toward reactivation relies on denaturation or
conformational alterations of the enzyme that make the recovery process less
favorable (Thompson, 1992). AChE post-inhibitory processes may be broadly
classified as those involving "non-reactivation" (kNR) and accounts for the timedependent loss of ability to reactivate regardless of process.

Non-Anticholinesterase Effects Associated with OP Exposure
Another neurotoxic effect induced by OP poisoning has been observed that
is not necessarily related to anticholinesterase potency. The malady has been
described as delayed neurotoxicity, and the effects are not seen until 8-14 days
following ingestion of or exposure to certain OP' s. The toxicity is manifested in
weakness in the lower limbs, progressing to paralysis. In severe cases, the upper
limbs may be affected with recovery slow and seldom complete (Johnson, 1980).
Delayed neurotoxicity has been attributed to inhibition and aging of neuropathy
target esterase (i.e., neurotoxic esterase, NTE) by a mechanism similar to that of
AChE (Johnson, 1987).
Delayed toxicity following exposure to trialkylphosphorothiolates has been
observed for animals where a steady decline in health was followed by death.
This delayed toxicity was determined not to be the result of a neurotoxic event
as discussed above, but probably due to morphological changes in the lung
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(Imamura, 1983).

Stereochemical Aspects of OP Compounds
An important structural feature common to many OP inhibitors warranting
discussion is stereochemistry. There are two locations where stereocenters may
appear, one of which is at the carbon atom of a ligand attached to the phosphorus
atom, and the other site for potential asymmetry is at the sp3-tetracoordinated
phosphorus atom when the four ligands attached are non-identical.

An OP

compound may contain one or both of these features, thus allowing three basic
types of chiral OP compounds: phosphorus stereogenicity, carbon stereogenicity,
and dual stereogenicity. Examples of OP compounds indicating the asymmetric
sites* are given in Figure 12.

0
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t
p,

CH/

17: malaoxon

/CH(CH 3 )2

O

18: isopropyl
methylphosphonoftuoridate

2: soman

Figure 12. Three Basic Types of OP Stereogenicity.

24

Phosphorus Stereochemistry: Inhibition of AChE
The asymmetric phosphorus center probably most effects the inhibitory and
post-inhibitory processes of AChE, the rationale being that this is the site of the
molecule that is immediately involved in the covalent modification of the serine
residue in the active site. This expectation is supported by a 4200-fold difference
m

inhibitory

potency

observed

for

the

enantiomers

of

isopropyl

methylphosphonofluoridate 18 (Figure 12) (Jarv, 1984). Several other examples
exist, however, where the stereoselective inhibition is not as great (Ooms, 1965;
Berman, 1989b; Hirashima, 1984; Armstrong, 1987; Eya, 1985; Lee, 1978).
Noteworthy, is the observation that among the stereoisomers examined (in the
preceding references), those with the S-configuration at phosphorus were generally
more potent inhibitors of AChE.
Jarv (1984) has suggested that the stereoselective inhibition of AChE by
OP-inhibitors may be due to steric limitations within binding domains of the
active site. In this model, an acidic residue in the active site hydrogen bonds to
the carbonyl of acetylcholine during normal ACh hydrolysis and presumably
facilitates the favorable positioning of the substrate for acylation of the serine
hydroxyl. It is hypothesized that this same acidic residue plays an analogous role
in the inhibition of ACh by an OP (Figure 13) (Jarv, 1984).
Examination and correlation of a list of asymmetric OP' s have permitted further
refinements to the active site topology and suggest that there exists three binding
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Figure 13. Proposed Binding Domains of AChE for OP Inhibitors.

domains that precisely complement the ligands about phosphorus.

Structural

studies suggest that domain D 3 probably accommodates the leaving group (X) of
an OP inhibitor, while the binding sites D 1 and D 2 are responsible for recognizing
the ligands that remain attached to phosphorus after phosphorylation (Jarv, 1984;
Benschop, 1988). If the positioning of the leaving group and the phosphoryl
oxygen are collectively maintained by domain D 3 and the acidic residue, and the
structural match between D 1 and D 2 domains and ligands R, and R 2 differ
sufficiently during inhibition, then binding of the inhibitor will be more favorable
for one phosphorus configuration accounting for differences in inhibition rates for
enantiomeric OP's (Jarv, 1984).
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Phosphorus Stereochemistry: Reactivation and Aging of AChE
When an OP containing an asymmetric phosphorus atom inhibits AChE,
two stereoisomeric forms of the phosphorylated enzyme are capable of forming
(Figure 14) (Berman, 1989a).

Therefore, any reactivation rate differences

observed for AChE inhibited by enantiomeric OP' s must be due solely to the
phosphorus configuration as it is the only structural difference present. It has
been suggested that the binding domains D 1 and D 2 described previously for
stereoselective inhibition may also be involved in the stereoselective reactivation
process (Jarv, 1984). The most dramatic display of stereoselective reactivation
cases would occur when AChE inhibited by one OP enantiomer reactivates while
the no reactivation is observed for the antipode. More commonly, OP inhibitor
enantiomers show negligible to modest (2-10 fold) differences in reactivation rate
(Berman, 1989a; Glickman, 1984).
Aging represents another post-inhibitory process that is influenced by the
phosphorus stereochemistry.

Aging differences for AChE inhibited by OP

stereoisomers have indeed been observed (Berman, 1989a; Glickman, 1984); a
notable case described aging of AChE inhibited by one OP stereoisomer while
AChE inhibited by the other stereoisomer did not undergo this process (Berman,
1989a). The basis for this difference is assumed to be steric hinderance making
the aging process less favorable for one configuration.
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Figure 14. Stereoisomeric Forms of AChE Inhibited by an OP Possessing an
Asymmetric Phosphorus Atom.

Ligand Stereochemistry: Inhibition of AChE
The stereochemistry of an OP ligand carbon atom may have its greatest
effect upon inhibition of AChE in contrast to reactivation or aging (or nonreactivation) reactions because the ligand bearing the asymmetric center may be
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displaced during the inhibition leaving an achiral phosphorylated enzyme. The
effect of carbon chirality on the kinetic constants,

~.

K0 and

~.

will be

considered.
Because enzymes are chiral molecules, it is anticipated that the
association/dissociation process as defined by K0 should differ for enantiomeric
inhibitors.

Once the enzyme-inhibitor complex has been formed, the ligand

stereochemistry may affect the subsequent phosphorylation,

~·

For example, if

binding domain D 3 demands or favors a particular orientation of two moieties (R3
and R4) about a ligand stereocenter for enantiomeric inhibitors due to electronic
or steric factors, the relative position of the reactive phosphorus center to the
nucleophilic serine hydroxyl may differ due to conformational limitations (Figure

-{1
HO

~
II

Ill

Figure 15. Influence of OP Ligand Stereochemistry upon AChE Inhibition.
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15; Examples I and II). Consequently, the

~values

for enantiomeric inhibitors

may differ when the phosphorus atom is not favorably situated for
phosphorylation.

However, if the phosphorus atom is the major positioning

determinant for the OP-inhibitor and the binding domain D3 in the active site
necessitates a favorable positioning of only one moiety (R 3) about the ligand
stereocenter (Figure 15, I and Ill), little difference in

the~

would be expected.

In this case, a difference in K0 may still be observed if there is a preference to
accommodate the R4 or R5 moiety.
Because

~.

K0 , and ~ are interrelated processes

(~

= k/I( 0 ), the effect of

ligand stereochemistry upon the overall inhibition of AChE (k) is dependent upon
the individual effects of the kinetic parameters (previously discussed). As a
consequence, enantiomeric OP inhibitors may differ in their inhibitory potency
depending on the contributive differences for kP and K 0 • However, few studies
have examined the effect of ligand stereochemistry upon the inhibition of AChE
(Hassan, 1968; Ohkawa, 1976; Wustner, 1973; Benschop, 1988), and the specific
relationship between stereochemistry upon both K0 and

~

has not been

thoroughly investigated. Furthermore, the differences observed in anti-AChE
potency due to ligand asymmetry (up to 5-fold) is generally less dramatic than
that of enantiomeric phosphorus center OP' s (2-fold to 56000-fold).
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Ligand Stereochemistry: Reactivation and Aging of AChE
Ligand stereochemistry also has been shown to affect the rates of both
reactivation and aging of AChE (Bucht, 1984; de Jong and Wolring, 1985; de
Jong and Kossen, 1985; de Jong, 1984).

AChE inhibited by soman 2 (P-

displaced upon inhibition) showed that the orientation of the pinacolyl ligand in
the active site of the inhibited enzyme [sterically] governed the accessibility of
the phosphorus atom by an approaching oxime.

The extent of reactivation

(percent recovered enzyme activity) differed between the reactivating species with
the most notable difference (approximately IO-fold) in favor of the (+c)configuration (de Jong and Kossen, 1985). However, the differences observed for
the rate of aging was less dependent upon the carbon configuration showing an
approximate 3-fold difference (Bucht, 1984).

OP' s Containing Dual Stereocenters: Inhibition of AChE

An OP with stereocenters at both carbon and phosphorus atoms may
further complicate the stereoselective inhibition of AChE.

To simplify this

discussion, a hypothetical OP inhibitor possessing dual stereocenters (existing as
four stereoisomers; RpR.0 RpSc, SpR.c, SpSc 1) will be considered in which the RiRc
stereoisomer is the strongest inhibitor (k) and the SrSc stereoisomers is the
1

Configurational designations for an OP with stereocenters at both phosphorus and carbon
are defined by the following example: RrSc = R configuration at the phosphorus atom, S
configuration at the carbon atom.
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weakest inhibitor of AChE.

The inhibitory potency of the two remaining

stereoisomers will depend upon the relative contributions of the phosphorus and
carbon stereochemistry to the overall inhibition of AChE. For example, if the
phosphorus configuration contributes more to the inhibitory strength, then it would
be anticipated that the RrSc stereoisomer would be a stronger inhibitor than its
enantiomer.

Alternatively, if the carbon configuration contributes more

significantly to the inhibitory profile then the SpRc stereoisomer is expected to
show greater inhibitory potency than that of the RrSc stereoisomer. The specific
roles of the phosphorus and carbon stereochemistries upon the inhibition of AChE
may be further inferred by examining their possible effect upon K 0 and kP.
OP inhibitors that contain both carbon and phosphorus stereocenters show
that phosphorus stereochemistry had a significant influence upon the
stereoselective inhibitory profile with the effect of carbon atom stereochemistry,
although observable, being of considerably less significance (Benschop, 1988;

Figure 16. 0-2-Butyl S-(Ethylthio)ethyl Ethylphosphonothiolate.
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Wustner, 1973). This phenomenon is illustrated by the inhibitor, (0-2-butyl S-2(ethylthio)ethyl ethylphosphonothioate (Figure 16) and the data is shown in Table
2 (Wustner, 1973).

Table 2. Inhibition of BEAChEa by S-2-(Ethylthio)ethyl
Ethylphosphonothioate Stereoisomers.
configuration
P
C

+
+
+

+

BEAChE
ki (M- 1min- 1x10-3)
65.3
54.5
0.63
1.45

aBovine Erythrocyte AChE.

OP's Containing Dual Stereocenters: Reactivation and Aging of AChE
When dual stereocenters are operative during the reactivation and aging of
AChE, two cases must be considered. First, the displacement of the chiral ligand
results in a phosphorylated enzyme that contains an asymmetric phosphorus
moiety, the effects of which have already been discussed (Section 1.15). The
second case involves an inhibitory pathway whereby the chiral ligand remains
attached. The kinetic implications are more complicated and are discussed below.
The individual effect of ligand stereochemistry on post-inhibitory pathways
has been discussed previously (Section 1.17), particularly the role of steric
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hinderance on the reactivating nucleophile in the displacement of the phosphoryl
moiety from the serine residue. In that instance, reactivation and aging, occurring
at either phosphorus configuration, may be influenced by the ligand carbon atom
stereochemistry. Further, the degree of steric hindrance imposed by one particular
carbon configuration of the ligand may differ from the antipode depending upon
the phosphorus configuration. These differences assume that the phosphorus
configuration could sufficiently alter the orientation of the ligand in the active
site. Thus, an interdependence between the phosphorus and carbon configurations
in such cases may be observed or anticipated during reactivation processes.
Few reports have explored the effects of stereochemistry upon the postinhibitory pathways of AChE inhibited by an OP possessing both carbon and
phosphorus stereocenters. The effects of carbon stereochemistry alone upon postinhibitory processes of such OP' s have been examined resulting in significant
differences (although considerably less than those observed for the inhibition
process) and were described previously in the Section 1.17.

Summary
The phosphorylation of AChE by an OP inhibitor and the subsequent
recovery of enzyme activity are intimately linked to the nature of the OP. In
particular, reactivity, steric effects, and stereochemistry have all been observed to
have effects upon such events. As a result, certain attributes of the AChE active
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site that complement of OP characteristics can be hypothesized and probed with
novel inhibitors.

CHAPTER 2
STATEMENT OF GOALS

Malathion: General
Malathion

6

[O,O-dimethyl-S-1,2-bis(ethoxycarbonyl)ethyl

phosphorodithioate] is one of the world's most widely used organophosphate
insecticides. Along with parathion methyl 7, parathion 8, chlorpyrifos 9 (Figure
2) (Eto, 1974), approximately 40,000,000,000 pounds of these four compounds
are sprayed in the U.S. annually (Stephens, 1991). Malathion's broad spectrum
of usage ranges from household to acreage application to control insects foraging
on grains, cotton, tobacco, and fruits. Recently, it has been employed to manage
the medfly problem in California (Barinaga, 1991). Malathion also has been
established in veterinary medicine (Osweiler, 1984), and in public health practices
as an anti-infective agent (Wester, 1989) to control insect vector-borne diseases
such as malaria (anopheles mosquito), dengue (aedes aegypti), and yellow fever
(aedes) (Caglioti, 1983).

Food safety concerns have encouraged limitations on the amount of
residues for crops treated with malathion.
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For fruits and vegetables, the
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maximum residue limit is less than 10 mg/kg while that for wheat and rye bran
is 20 mg/kg (Cheminova, 1987). As with most OP insecticides, environmental
persistence of malathion is low. For most fruits, vegetables and grains, the

t 112

period is approximately two days while in soil samples and field applications the
t 112 is 8.2 h and 2 h, respectively (Cheminova, 1987; Miles, 1991).

(A) 13-elimination

+

organic
solwnt

s

(B) Phosphorothiolate Hydrolysis

II
__ P,

I

CH30
CH30
water

Figure 17. Hydrolysis of Malathion.

+

"OH
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Although relatively stable to acidic aqueous conditions (t 112 = 6.5 days,
pH2.6, 27 °C), the decomposition of malathion is catalyzed by hydroxide (t 112 =
2.4 h, pH 10.8, 0 °C) and depending on the type of solvent, one of two
mechanisms is possible (Figure 17).

While B-elimination is favored in organic

solvent (Figure 17, A), SN2-type displacement of diethyl mercaptosuccinate
predominates in aqueous conditions (above pH 9). With regard to thermostability,
the malathion content after dark storage for 2 years at 40 °C decreased from
96.2% to 89.6% while the t 112 of malathion stored at 55 °C was 17 weeks
(Cheminova, 1987).

Malathion: Mode of Action
The popularity of malathion' s usage has been promoted by its relatively
low mammalian toxicity (Table 3).

This is primarily due to endogenous

carboxylesterases that rapidly degrade malathion to the monoacids (Figure 18),
which are found as urinary metabolites (O'Brien, 1967). Both the a-monoacid
20, which is generally found in greater quantity, and the B-monoacid 21 are
virtually non-toxic to mammals (Chen, 1969; De Matteis, 1989; Ryan, 1985).
Two malathion carboxylesterases responsible for this detoxication (in rats) have
been identified and designated as Fraction A and B. Fraction A preferentially
converts malathion to the a-monoacid 20 while the B-monoacid 21 is the
preferred product formed from hydrolysis by Fraction B (Mallipudi, 1980).
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Table 3. Relative Toxicity of Biologically
Active Compounds
Compound

LD50 mg/kg (oral, rats)

glucose
malathion
ethanol
asp1nn
valium
caffeine
cocaine
strychnine

35,000
12,500
10,000
3,750
710
300
17
5

Although malathion maintains a low mammalian neurotoxicity, some
experimental results suggest that it may be carcinogenic (Zimmerman, 1990). In
addition, there exists uncertainties as to whether malathion is teratogenic since

Figure 18. Hydrolysis of Malathion by Carboxylesterase.
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studies have given both positive and negative results (Zimmerman, 1990). Daily
doses of 1/50th the LD50 fed to rats resulted in reduced survival of the progeny
as well as apparent growth retardation (Cheminova, 1987).
The species selectivity of malathion toward insects (and fish) is largely a result
of a deficiency in detoxifying carboxylesterases by these organisms, which then
permits malathion to undergo oxidation to the oxon (P=O) metabolite, malaoxon
22 [O,O-dimethyl-S-1,2-bis(ethoxycarbonyl)ethyl phosphorothionate] (Figure 19)
(Cohen, 1984; Matolczy, 1988). This thionate-oxon conversion is common to the
class of phosphorothionate insecticides and while phosphorothionates (P=S) are
generally not effective inhibitors of AChE, bioactivation to the oxon analogues
(P=O) by mixed function monooxygenases in insects (Cohen, 1984) creates more
potent inhibitors of AChE (De Matteis, 1989). For example, malaoxon is a 1,000fold stronger AChE inhibitor than malathion and nearly 80-fold more toxic in vivo
to the rat (malathion, LD50 = 12,500 mg/kg; malaoxon, LD50 = 158 mg/kg)

6: malathion

22: malaoxon

Figure 19. Bioactivation of Malathion.
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(Cheminova, 1987; Ryan, 1985; Umetsu, 1977).
The increased inhibitory potency of oxon analogues of phosphorothionates
is primarily due to the more reactive nature of the P=O bond as discussed
previously (Matolczy, 1988).

It also has been hypothesized that the less

electronegative sulfur atom of the P=S bond (compared to the P=O oxygen atom)
may compete with small alkoxy ligands for hydrophobic binding domains of the
AChE active site. In this instance, the serine hydroxyl is not positioned correctly
for attack at the phosphorus atom. Thus, the absence of the P=S functionality in
the oxon analogues of phosphorothionates may enhance their affinity for the
active site, thereby increasing their anti-AChE potency through both reactivity and
orientation. (Maxwell, 1992).

Malathion: Impurities
Whereas purified malathion is relatively innocuous to mammals, several
more toxic impurities (Figure 20) result from the manufacture or storage and have
been shown to potentiate or enhance the toxicity of malathion formulations
(Aldridge, 1979; Lin, 1984; Toia, 1980; Mallipudi, 1980).
potentiator of these impurities is isomalathion 12.

The strongest

A 0.5% isomalathion

contamination of malathion formulations reduced the LD50 from 12,500 to 4400
mg/kg (Toia, 1980, Umetsu, 1977). Isomalathion has been shown to be not only
an inhibitor of AChE but also an inhibitor of the mammalian detoxifying enzyme,
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23: 0, 0, S-trimethylphosphorodithioate

24: 0, O,S-trimethylphosphorothiolate

25: O,S, S-trimethylphosphorodithiolate

12: isomalathion

Figure 20. Impurities Found in Commercial Malathion Formulations.

carboxylesterase (Talcott, 1979; Toia, 1980; Lin, 1984; Ryan and Fukuto, 1985).
When carboxylesterase is inactivated, the normal detoxication pathway is removed
(Section 2.2.), and metabolic activation from malathion to malaoxon dominates
the metabolism causing the latent toxicity (anti-AChE potency) to be realized in
mammals (De Matteis, 1989; Cohen, 1984).

Malathion: Stereochemistry
A structurally interesting feature of malathion is the presence of an
asymmetric carbon at the succinyl ligand resulting in two enantiomers (Figure 21).
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It is expected that the enantiomers of malathion would interact stereoselectively
with the varying enzymes encountered in vivo such as cholinesterases,
carboxylesterases, and oxidizing enzymes. Enantiomers of the closely related
0,0-diethyl malathion 26 enantiomers (not used in agriculture) were prepared and
the S-stereoisomer 26b was found to be a 1.9-fold better substrate for rat liver
carboxylesterase than the R-stereoisomer 26a (Hassan, 1968). However, since its
introduction over 40 years ago the synthesis of the malathion (0,0-dimethyl)

6a: (R)-malathion

26a: (R)-0,0-diethyl malathion

S

II

902C2H5
=

~H50_.-~..........S~C02C2H5
C2 H50
6b: (S)-malathion

26b: (S)-0,0-diethyl malathion

Figure 21. Enantiomers of Malathion and 0,0-Diethyl Malathion.
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enantiomers has not been achieved.

Malaoxon
As discussed previously, malaoxon is the bioactivated form of malathion,
responsible for its insecticidal (anti-AChE) activity. Although it has been found
as a minor impurity in commercial malathion formulations, it was determined that
malaoxon is not responsible for the potentiation of malathion toxicity that was

22a: (R)-malaoxon

27a: (R)-0,0-diethyl malaoxon

22b: (S)-malaoxon

27b: (S)-0,0-diethyl malaoxon

Figure 22. Enantiomers of Malaoxon and 0,0-Diethyl Malaoxon.
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observed for other impurities (Aldridge, 1979). Although malaoxon is both an
inhibitor and a substrate for mammalian carboxylesterase, hydrolysis of the
carboxylic esters is the preferred metabolic pathway. (Ryan and Fukuto, 1985,
Aldridge, 1979).
Like malathion, an asymmetric carbon center exists on the succiny1 ligand
of malaoxon allowing two enantiomers (Figure 22). Consequently, it is expected
that these stereoisomers will interact stereoselectively with AChE and
carboxylesterases. The 0,0-diethyl analogues of the malaoxon enantiomers 27
(Figure 22) were prepared and examined for their anti-AChE and anticarboxylesterase potency (Hassan, 1968). (R)-0,0-Diethyl malaoxon 27a was a
4.4-fold stronger inhibitor of bovine erythrocyte AChE, and an 8.3-fold stronger
inhibitor of rat liver carboxylesterase than its antipode 27b (Hassan, 1968).
However, 0,0-dimethyl malaoxon enantiomers have not yet been prepared nor
have their differential phosphorylating capabilities been examined.

Isomalathion
Isomalathion (Figure 20) is the S-methyl isomeride of malathion found in
commercial formulations of the insecticide, and is formed as a result of the
thiono-thiolo rearrangement (Section 1.5.).

Like most S-alkyl isomerides of

phosphorothionate insecticides, isomalathion shows dramatically enhanced antiAChE potency relative to malathion for the reasons previously mentioned, i.e.
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chemical reactivity of the P=O bond, and the decreased p1t-d1t contribution of the
S-alkyl ligands (Fest, 1973; Thompson, 1989). Consequently, isomalathion is a
3000-fold more potent anti-AChE agent than malathion (Thompson, 1989).
Like malaoxon, isomalathion inhibits the detoxifying decarboxylesterases,
but unlike malaoxon, potentiates the toxicity of malathion (Lin, 1984). Of all the
impurities found in malathion formulations, isomalathion is the strongest
potentiator. The isomalathion content in malathion formulations, therefore, has
been a matter of considerable concern, especially since the 1976 epidemic
malathion poisoning in Pakistan in which 2800 Pakistani spraymen were acutely
poisoned while 5 died during a malaria control program (Baker, 1978; Iyer,
1984). The poisonings were attributed to the unusually high isomalathion content
of the formulation employed (Aldridge, 1979; Iyer, 1984).
Besides the enhanced anti-AChE potency of isomalathion, another
important consequence result from the isomerization of malathion to isomalathion,
is the generation of a new asymmetric center at phosphorus.

During the

isomerization, the asymmetric carbon center of malathion on the succinyl ligand
is maintained, therefore, four stereoisomers of isomalathion are produced (Figure
23).

The configurational designations for the isomalathion stereoisomers is

described by the following example: (JR,3S) = R configuration at the phosphorus
atom, S configuration at the carbon stereocenter. As discussed previously for
OP' s possessing dual stereocenters, it is anticipated that the dual stereocenters

46

(1R,3~-isomalathion

12b: (1R,3S)-isomalathion

12c: ( 1S,3~-isomalathion

12d: ( 1S,3S)-isomalathion

12a:

Figure 23. Stereoisomers of Isomalathion.

present in isomalathion will contribute collectively toward the inhibition of AChE
and possibly, reactivation and aging.

Summary
Because of the continued global application of malathion formulations,
which contain various levels of the impurities malaoxon and isomalathion, it is
important to fully understand the role of stereochemistry upon their modes of
action. To date, however, there exists no definitive report that details the effect
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of the stereochemistry of these compounds upon their interactions with varying
enzymes encountered in vivo; i.e. carboxylesterases, oxidizing enzymes, and
AChE.
The goal of this dissertation is to identify the anti-AChE profiles of the
individual stereoisomers of malathion 6, malaoxon 22, and isomalathion 12, and
to correlate these profiles with the specific stereochemistry of these compounds.
Furthermore, the effect of phosphorus and carbon stereochemistry upon the postinhibitory fate of AChE inhibited by the individual isomalathion stereoisomers
will be examined. In order to achieve the aforementioned goals, procurement of
the individual stereoisomers of malathion, malaoxon, and isomalathion is
necessary. However, because these enantioenriched materials were previously
unavailable, a preliminary goal of this dissertation will be the first successful
syntheses of these individual stereoisomers.

CHAPTER 3
SYNTHESIS OF MALATHION, MALAOXON, AND
ISOMALATHION STEREOISOMERS

Synthesis of Racemic Malathion
Racemic malathion 6 was readily prepared by literature methods from the
reaction of 0,0-dimethyl phosphorodithioic acid and diethyl maleate 27 (Eqn. 7)
(March, 1956).

1

H NMR analysis of the product revealed the characteristic

phosphorus-proton vicinal coupling observed for 0-methyl phosphorothionates,
which resulted in a doublet at 3.8 ppm (Thompson, 1989; Thompson, 1992).
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P

NMR showed a single resonance at 96.2 ppm consistent with chemical shifts of
related phosphorothionates (P=S).

(CH30hP(S)SH

TEA

~

(7)

27

6
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Attempted Synthesis of Malathion Enantiomers from Diethyl Bromosuccinate
The report by Hassan and Dauterman (1968) described the preparation of
the enantiomers of the 0,0-diethyl analogues of malathion 26 (Scheme 1).
Diazotization of (S)-aspartic acid 28a in the presence of sodium bromide yielded
(S)-bromo succinic acid 31a (Holmberg, 1928), which occurred with overall
retention of configuration. Formation of the B-lactone 30a was hypothesized to
occur first with inversion, followed by ring opening of the lactone with bromide
resulting in a second inversion and overall retention (Holmberg, 1928).
Displacement of the bromide by potassium 0,0-diethyl phosphorodithioate 33
(Scheme 1) occurred with inversion of configuration yielding (R)-0,0-diethyl
malathion 26a (Hassan, 1968).
Although the preparation of the malathion 6 (0,0-dimethyl) enantiomers
seemed a simple extension of the above method, displacement of the bromide
with 0,0-dimethyl phosphorodithioate 34 under the same conditions failed.
Variations in reaction conditions such as temperature, solvent, and time also were
unsuccessful. Our results may, in part, explain the previous focus upon the 0,0diethyl analogues by Hassan and Dauterman (1968).
The failure of 0,0-dimethyl phosphorodithioate to displace the bromide
may be due to a field effect where the electron donating effect of the methoxy
ligand compared to that of the ethoxy is less, thus, decreasing the nucleophilicity
of the dithioate. Such field effects have been observed for phosphoric ester acids
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where the acidity decreased with increasing size of the alkyl groups (Fest and
Schmidt, 1973) as larger groups were less able to stabilize the conjugate base by
releasing electron density into the dithioate.
Further pursuit of the approach of Scheme 1 was abandoned for two
reasons: first, three opportunities for racemization at the carbon stereocenter were

28a

~
30a

29a

0

32a

31a

33 R =Et

34 R = CH3

26a R =Et

6a R=CH3

Scheme 1. Synthesis of (R)-0,0-Diethyl Malathion from (S)-Aspartic Acid.
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possible and second, the simultaneous success of another method gained our
attention.

Synthesis of Malathion Enantiomers from Diethyl Malate
This new strategy was designed using the same nucleophile (0,0-dimethyl
phosphorodithioate potassium salt 34) but sought to displace a better leaving
group. It was believed that if the hydroxyl moiety of diethyl malate 36 could be
converted to a better leaving group than bromine, it could be more easily
displaced (Scheme 2). In addition, only one inversion would occur at the carbon
stereocenter (Scheme 2) compared to the three reactions at the carbon stereocenter
(Scheme 1).
(S)-Malic acid 35a was converted to the diethyl ester 36a (Cohen, 1984),
afterwhich the hydroxyl was converted into a series of leaving groups including
the tosylate, mesylate, and triflate. The (S)-tosylate 37a and (S)-mesylate 38a
were prepared by reaction of (S)-diethyl malate with p-toluenesulfonyl chloride
(tosyl chloride) or methanesulfonyl chloride (mesyl chloride), respectively. The
(S)-triflate 39a was prepared by reaction of trifluoromethanesulfonic anhydride
(triflic anhydride) with 36a. Identification of the tosylate, mesylate, and triflate
was determined by 1H and 13C NMR. The 1H NMR of the tosy late 37a showed
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a. p-CH3C5H4S02CI
b. CH3S02CI
35a

36a

37a X=p-CH3C5H4S020-

c. (CF3S02)0

6a

38a X=CH3S02039a X=CF3S020-

Scheme 2. Synthesis of (R)-Malathion from (S)-Malic Acid.

the p-substituent patterns for the aromatic resonances as well as the p-methyl
singlet.

1

H NMR of the mesylate 38a revealed an additional 1H methyl singlet

(3H) of the methanesulfonyl moiety to the spectrum of diethyl malate. The 13 C
spectrum of the triflate 39a showed the addition of a quartet corresponding to C-F
coupling by the trifluoromethyl substituted carbon.
Nucleophilic substitution reactions with 0,0-dimethylphosphorodithioate
34 and the hydroxyl activated compounds described above were attempted varying
the time, temperature, and solvent. However, only the (S)-triflate 39a entered into
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the reaction with 34 (THF, 0°C) to give (R)-malathion 6a in 95% yield from
diethyl malate. (SJ-Malathion 6b was prepared analogously starting with (R)malic acid 35b. 1H, BC, and 31 P NMR spectra of the malathion enantiomers were
identical to that of racemic material.

Specific rotations of these enantiomers

supported the success of this method ((R)-malathion 6a, [a] 240 = +79.7°; (S)malathion 6b, [a] 27 0 = -80.0°). In an attempt to quantify enantiomeric excess, 1H
and

31

P NMR analyses of the enantiomers were conducted with a chiral shift

reagent (tris-{ 3-[heptafluoro(hydroxy)butylidene]-(+)-camphorato }europium(Ill)),
however, no chemical shift separation of resonances from a racemic mixture was
observed.

Synthesis of Racemic and Enantioenriched Malaoxon with m-CPBA
The preparation of racemic malaoxon 22 from racemic malathion 6 had
been reported previously using m-chloroperbenzoic acid (m-CPBA) as the oxidant
(Bellet, 1974). This peracid promoted transformation is proposed to proceed via
a three-membered ring intermediate (Scheme 3) (Bellet, 1974). Although the 1H
and BC NMR spectra of malathion and malaoxon were expectedly similar, the 31 P
NMR phosphorus resonance of malaoxon was shifted significantly upfield (28.3
ppm) from that of malathion (96.2).
Both (R)- and (S)-malathion (6a and 6b) were converted to (R)- and (S)malaoxon (22a and 22b), respectively, with m-CPBA in 25% yield (Scheme 3).
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Specific rotations of the malaoxon enantiomers gave evidence of the success of
this method ((R)-malaoxon, [a] 25 0

= +46.7°; (S)-malaoxon, [a] = -43.5°).
27

0

Synthesis of Malaoxon Enantiomers by Oxidation of Malathion
Enantiomers with MMPP
In order to increase the efficiency of this oxidation step, a better reagent
for this transformation was sought. Hydrogen peroxide, t-butyl hydroperoxide,
trifluoroacetic anhydride, potassium periodate all were reacted with malathion in
attempts to increase the yield of malaoxon. Some of these reagents had been used
successfully to effect oxidative desulfuration of phosphorothionates (Helinski,
1990; Stec, 1976). However, both peroxides resulted in extensive decomposition
of the starting material while no reaction was observed with the latter two
reagents. Since MMPP 46 (magnesium monoperoxyphthalate) has recently gained
acceptance as a substitute for m-CPBA in other oxidation reactions (Brougham,
1987), it was thought that it may effect the desired transformation. Refluxing
malathion overnight with MMPP in CH2Cl 2 gave a 52% yield of the malaoxon
enantiomers doubling the conversion using m-CPBA.
The success of this transformation prompted an investigation into the utility
of MMPP for similar conversions of several other thionates (Scheme 3) to the
corresponding oxons (Jackson, Berkman, and Thompson, 1992). In all cases,
acceptable yields were obtained (51-72%). It also was found that the
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m-CPBA
or
MMPP

s

II

p
CH30--/ ' x
CH30

6 X= -SCH(C02Et)CH2C02Et
7 X =-O-Ph-p-N02

9 X = -0-(3,5,6-03-2-pyridinyl)

-

- Mg++

40 X = -0-2,3,5-03-2-Ph

23 X= -SCH3

0
-

II
p

46 MMPP

CH30--/'x
CH30
22 X= -SCH(C02Et)CH2C02Et
41 X= -O-Ph-p-N02

42 X = -0-(3,5,6-Cl3-2-pyridinyl)
43 X= -0-2,3,5-C13-2-Ph
24 X= -SCH3

nrCPBA
or
MMPP

45a

44

Scheme 3. Conversion of Thionates to Oxons.
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stereochemical outcomes using MMPP were superior to that of m-CPBA. The
conversion of thion 44 to axon 4Sa occurred with complete retention of
phosphorus configuration while reaction with m-CPBA resulted in a 3.85: 1
diastereomeric ratio of axons 4Sa and 4Sb. The superior results obtained with
MMPP was attributed to its lower reactivity than m-CPBA.

Synthesis of Racemic Isomalathion
The isomerization of racemic malathion 6 was conducted as previously
reported (Thompson, 1989) by dealkylation with potassium ethyl xanthate
(EtOCS(S)K) followed by realkylation with dimethyl sulfate (Eqn. 8). Positive
identification of racemic isomalathion 12 was accomplished by comparison to
known material.

1

H NMR revealed the presence of a new phosphorus-coupled

doublet (2.4 ppm) corresponding to the S-methyl protons as a result of the
isomerization. A new resonance also was observed in the 13 C NMR spectrum

(8)
6

a. EtOC(S)SK b. (CH30)S02

12
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(centered at 13 ppm), corresponding to the -SCH 3 moiety. Only the 31 P NMR
spectrum identified the two diastereomers showing two resonances separated by
1.5 ppm and centered at 5 8 ppm.

Synthesis of 13 C-S-methyl Isomalathion
In an effort to aid the mechanistic evaluation of the interaction of

isomalathion with AChE, 13C-enriched (13CH 3S)-isomalathion (12') was desired.
Using the preparative method for racemic isomalathion, 13 C-labeled isomalathion
was obtained by substituting (13CH 30) 2S0 2 in the second step.

1

H NMR of the

product showed considerable carbon-proton coupling of the S-methyl doublet (J

= 144 Hz) while 13C NMR showed the expected enhancement of the labeled Smethyl carbon.

Attempted Chromatographic Separation of lsomalathion Diastereomers
Since control over the chiral carbon center had been established using
enantioenriched malic acid starting materials in the synthesis of the malathion
enantiomers, the thionate-thiolate isomerization reaction would give the putative
diastereomeric mixture of isomalathion (Scheme 4), which could be separated
chromatographically.

The dealkylation-realkylation sequence described in

Equation 8 was conducted with (R)- and (S)-malathion (6a and 6b) to afford
either (JRS,3R)- or (JRS,3S)-isomalathion in 72% yield (Scheme 4) as a mixture
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l

6a

l

a. EtOC(S)SK
b. (CH30)S02

12a

6b

12b

+

+

12c

12d

c. chromatographic separation
of diastereomers

~

1"'

Scheme 4. Synthesis of Isomalathion Diastereomers.

of diastereomeric pairs (12ac and 12bd), respectively.
As indicated in Synthesis of Racemic Malathion, isomalathion
diastereomers were most readily detected by

31

P NMR, which provided an

analytical tool to study the degree of resolution or separation of a single
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stereoisomer from a diastereomeric pair. Traditional attempts at gravity silica gel
chromatography were unsuccessful (numerous solvent mixtures were examined).
For example gravity silica gel chromatography (petroleum ether:ethyl ether, 1: 1)
produced fractions enriched in the front flowing diastereomer (35% diastereomeric
excess) followed first by 50/50 mixtures and later by slightly enriched mixtures
of the slow band (10% diastereomeric excess). Reapplication of the front flowing
enriched fractions to the column gave only 1% of the single diastereomer
followed again by the elution of varying degrees of the diastereomer mixture.
Reverse phase TLC also was tried, however, only one elution band was
detected. Analytical chiral HPLC (d-phenylglycine and 1-leucine) could partially
resolve a diastereomeric mixture but not to baseline resolution (Figure 24). Thus
all chromatographic approaches failed, possibly explaining the 30 year dearth of
reports on isomalathion stereoisomerism.

I

I

I

I

8

12

16

20

time (min)

Figure 24. Partial Resolution of Isomalathion Diastereomers via Chiral
HPLC.

60

Attempted Synthesis of lsomalathion Stereoisomers Using a Chiral Auxiliary
With the failure of the previous approach that would have allowed control
over the asymmetric carbon center followed by resolution of the asymmetric
phosphorus center, a convergent synthesis was planned where control of both
stereocenters was achieved in separate steps, followed by the appropriate coupling
of the 2 asymmetric "pieces." Previous reports indicated that resolution of certain
organophosphorus compounds could be achieved by the use of chiral auxiliaries
(Valentine, 1984; Koizumi, 1978).

Because it had proved useful for the

preparation of isoparathion methyl enantiomers 49a/49b (Scheme 5; Ryu, 1991a),
/-proline ethyl ester was selected as the chiral auxiliary for the resolution of
isomalathion stereoisomers (Scheme 6) with anticipated success.
Thiomethyl phosphoric dichloride 47 was prepared from thiophosphoryl
chloride via methanolysis followed by thermal isomerization at 100 °C. Reaction
of 47 with /-praline ethyl ester in the presence of TEA yielded the desired
chlorophosphoramidothiolate diastereomers 50, which were resolved by column
chromatography.

The

1

H NMR

spectrum showed the

characteristic

phosphorothiolate methyl doublet at 2.5 and 2.4 ppm for the fast and slow bands,
respectively. The ethyl ester protons were also present for both diastereomers in
addition to the pyrrolidine ring protons.

13

C NMR spectra of the diastereomers

were similar but again the 31 P NMR spectra for the diastereomers were resolved,
differing by 0.4 ppm. Specific rotations for the two stereoisomers also were
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obtained (fast band, [a] 0 24 = -52.6° (c = 1.04, CHC1 3); slow band, [a.] 0 24 = -48.2°
(c = 1.15, CHC1 3).

Thus, control over the phosphorus stereochemistry was

managed.
(S)-diethyl mercaptosuccinate 51a was prepared via reaction of sodium
hydrogen sulfide with enantioenriched (R)-diethyl bromosuccinate 32b, which
had been prepared earlier (Scheme 1). Thus, with the two chiral "pieces" in hand,
the stage was set for their coupling. Racemic diethyl mercaptosuccinate prepared
from esterification of mercaptosuccinic acid (Ailman, 1965) was used first to
study the coupling reaction to avoid unnecessary consumption of chiral materials,
and was reacted with the fast-band diastereomer of the phosphoramidothiolate 50
to afford the phosphoramidodithiolate 52. 1H NMR showed the S-methyl doublet
and the pyrolidine protons observed for 50. The resonances for the ethyl ester
methyl protons of both the prolinate and succinate moieties were superimposed
and appeared as multiplets. This was also the case for the methylene protons of
the ethyl esters. Two resonances at 47.52 and 48.12 ppm were observed in the
31

P NMR spectrum for each of the diastereomers, 52b and 52d, due to the use of

racemic 51.
The final stage of this method, exchange of the chiral auxiliary for a
CH 30- moiety, is normally straightforward (Ryu, 1991a). Unfortunately, both
mineral acid (H+) or Lewis acid (BF 3) promoted methanolysis were unsuccessful

62

1. /-proline ethyl ester
2. p-nitrophenol
3. separate diastereomers

J

J

Scheme 5. Synthesis of Isoparathion Methyl Enantiomers Using a Chiral
Auxiliary.
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Scheme 6. Attempted Synthesis oflsomalathion Stereoisomers Using a Chiral
Auxiliary.
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in yielding isomalathion as indicated by TLC. One possible explanation of these
results may be attributed to the presence of three electron donors connected to the
phosphorus atom, which compete for the primary acid coordination site.

Attempted Synthesis of Isomalathion Stereoisomers from Isoparathion Methyl
While the stereoisomers of isoparathion methyl 49 were available through
a prior study (Ryu, 1991b), an alternative to the coupling strategy was envisioned.
Because p-nitrophenoxy is the primary leaving group of isoparathion methyl, it
was thought that an SN2-type reaction could be conducted at the asymmetric
phosphorus of isoparathion methyl with optically pure diethyl mercaptosuccinate

Slb as the incoming nucleophile (Eqn 9).

Again, racemic diethyl

mercaptosuccinate was utilized to avoid unnecessary consumption of the chiral
pool. Unfortunately, multiple variations within this strategy (varied solvents:

(9)
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ethyl ether, THF, and DMF) with up to 5 equivalents of 51 were unsuccessful.
In this instance, 51 probably acts to dealkylate the phosphorus ester rather than
serve as a nucleophile.

Synthesis of Isomalathion Stereoisomers via Alkaloid Resolution
Several prior studies showed that alkaloid resolution was an effective
procedure for the preparation of enantioenriched phosphorothiolates (Valentine,
1984; Aaron, 1958; Aaron, 1960; Hilgetag, 1969; Hilgetag, 1959).

However,

there are very few examples of phosphorodithioate resolution with alkaloids. The
general method for this type of resolution involves either conducting an acid-base
reaction with a phosphorothioic acid and the alkaloid, or dealkylating a
phosphorothionate

ester

with

the

alkaloid

to

form

the

alkylated

alkaloid/phosphorothioic acid salt.
Dealkylation of (S)-malathion 6b with strychnine, brucine, and quinine was
performed followed by attempts at fractional crystallization of the resulting
alkaloid salts (Scheme 7). Fractional crystallization of phosphorothioate-alkaloid
salts is commonly performed in methanol or ethanol, however, the alkaloid salts
of (S)-malathion (53b and 53d) were readily soluble in these solvents. Initial
attempts dissolved the salts in methanol followed by the addition of ethyl ether
to affect cloudiness. Heat was applied to affect solution, which subsequently was
stored at -20°C overnight. As a result, a first crop of crystals was obtained for
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6b

12b

1. strychnine
2. fractional crystallization

12d

Scheme 7. Synthesis of Isomalathion Diastereomers via
Alkaloid Resolution: Method I.

strychnine and brucine salts while quinine failed to produce any crystals under
these conditions. These first crops were analyzed by 1H, 13C, and 31 P NMR and
enrichment of one diastereomer of the (S)-malathion-alkaloid salt mixture was
most notably and easily observed in the 31 P NMR spectrum as revealed by two
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resonances differing by approximately 1 ppm. The most significant enrichment
of the alkaloid salts was observed for the strychnine derivatives in which

31

P

NMR revealed approximately 70% enrichment of the downfield diastereomer 53b.
Thus, preparative resolution of the isomalathion
stereoisomers via strychnine salts was pursued using 31 P NMR as the definitive
analytical tool used to determine diastereomeric purity.
Further fractional crystallization of the first strychnine salt crop (downfield
diastereomer) 53b was achieved stepwise, through repeated recrystallization in
methanol-ethyl ether solutions (Figure 25). However, the [unexpected] limit of
diastereomeric purity was 95%. To achieve higher resolution of the downfield
(S)-malathion-strychnine salt 53b, several solvent mixtures for recrystallization
were examined. A mixture of ethylene glycol, absolute ethanol, and ethyl ether
eventually provided the downfield alkaloid salt in 100% diastereomeric purity by
3Ip

NMR.
The mother liquor from the first crystallization of the (S)-malathion-

strychnine salt provided no precipitated salts upon cooling (-20 °C, 5 days). The
solution was concentrated to an glassy solid that showed approximately 60%
enrichment of the upfield diastereomer 53d by 31 P NMR. Further enrichment was
first attempted by crystallization with a methanol-ethyl ether mixture as described
for the downfield diastereomer. However, no further enrichment of the resulting
crystals resulted. Several solvent mixtures were examined to further enhance the
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Figure 25. 31 P NMR Analysis of the Sequential Enrichment of Desmethyl
Malathion-Strychnine Following Fractional Crystallization.

diastereomeric purity of this diastereomer (53d) and as a result, a mixture of
methanol, ethyl acetate, and ethyl ether produced the completely resolved
diastereomer after repeated recyrstallization. It was later found that if the initial
crystallization was performed with this solvent mixture, the first crop of crystals
produced was the downfield diastereomer 53b in approximately 70% enrichment
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while the mother liquor, upon standing at room temperature, conveniently
deposited the upfield diastereomer 53d in 100% diastereomeric purity.

As a

result of the above mentioned success, resolution of the diastereomeric strychnine
salts of (R)-malathion (53a and 53c) was undertaken. Initially, a methanol-ethyl
ether mixture was employed for the fractional crystallization and produced a first
crop with an approximate 70% enrichment of the downfield diastereomer 53c as
identified by

31

P NMR.

Repeated recrystallization with methanol-ethyl ether

ultimately produced 53c in 100% purity. In results similar to the desmethyl-(S)malathion-strychnine resolution, no crystals could be obtained using methanolethyl ether from the mother liquor of the first crop. Experimentation with various
solvent mixtures showed that repeated recrystallization of the mother liquor with
chloroform-ethyl acetate produced the completely resolved upfield diastereomer
53a. Again, it was found that if the first crystallization was performed with this
solvent mixture, the first crop that was deposited was enriched approximately 70%
with 53c while the mother liquor produced 53a in 100% purity upon standing at
room temperature.
In addition to NMR analysis of the malathion-strychnine salts 53, specific
rotations and melting points also were obtained (Table 4). The individual salts
of each diastereomeric pair were identified as the levorotatory or dextrorotatory
stereoisomer with respect to the phosphorus stereochemistry because the carbon
configuration was known from malic acid. Similarities observed for melting
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Table 4. Physical Data of the Malathion-Strychnine Salts. a
P NMR (o)

mp {6C)

+32.2 (0.25)

67.20

159-160

53b (JR,3S)

-45.1 (0.26)

68.12

189

53c (JS,3R)

+16.1 (0.31)

68.10

181-182

53d (JS,3S)

-61.7 (0.31)

67.18

158-159

compound

[a]D22

53a (JR,3R)

31

irotations performed in CHC1 3; concentrations in parenthesis,
g/100 ml.

points and

31

P NMR data supported correlation of the phosphorus and carbon

configurations (excluding that of strychnine) for the salts that were later
confirmed through comparison to a salt analyzed by x-ray crystallography.

Assignment of Absolute Configurations of the Isomalathion Stereoisomers
In an effort to assign the absolute configuration of the carbon and

phosphorus stereocenters of the resolved desmethyl malathion-strychnine salts, xray crystallographic analysis was desired. In order to prepare crystals for x-ray
crystallography, recrystallization of the resolved salts was performed in their
respective solvent mixtures at twice the dilution normally used. Recrystallization
of 53c in methanol:ether (1 :5) ultimately provided crystals that were suitable for
x-ray crystallographic analysis.
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The crystal structure of the submitted crystal was solved and revealed a
monoclinic unit cell with dimensions of 8 x 8 x 14 A (Table 5; Berkman, 1993).
Methylstrychninium cations were found in bilayer sheets that alternated with
bilayer sheets of desmethyl malathion anions (Figure 26). This bilayer packing
of strychnine salts had been noted previously (Gould, 1984; 1987). Ultimate
determination of the structure was aided by prior knowledge of the structure and
absolute configuration of strychnine (Peerdeman, 1956).

As a result of this

analysis, the configuration of the phosphorus stereocenter was identified as S
(Figure 27). The carbon stereocenter configuration of 53c was identified as R and
was expected because this salt was initially prepared from the reaction of (R)malathion strychnine. Thus, with the absolute configuration of one salt known,
the configuration of the other three were assigned.
With the four alkaloid salts resolved, realkylation with dimethyl sulfate to
form the respective stereoisomers of isomalathion was conducted.

This step

afforded the desired isomalathion stereoisomers in approximately 70% yield,
which were characterized by specific rotations and 1H,

13

C, and 31 P NMR. A

limitation of 31 P NMR analysis of the isomalathion stereoismers was the inability
to detect enantiomer impurities. To address this problem, a HPLC technique was
developed that resolved the four individual stereoisomers (Figure 28). Compared
to known racemic material, a most striking difference was the presence of a single
resonance in the 31 P NMR spectra for each stereoisomer instead of the two
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Table 5. Crystal Data for Strychnine Salt 53c.a
molecular formula
molecular wt (amu)
g/cm3
crystal system
space group
dcaJcd•

z
A
b, A
c, A
V, A3
a,

crystal size (mm)
total reflections
unique reflections
observed (I > 2.5cr(/))
final R
final Rw
goodness of fit

C 31 H41 N 20 8PS 2
664.77
1.37
monoclinic
P2 1

2
8.3925
8.0054
24.3050
1614.9
0.4 x 0.24 x 0.20
5806
3063
2417
0.0491
0.0463
0.978

llfrom Berkman et al. Acta Cryst. 1993, C49, 554.

observed for the diastereomeric mixtures. HPLC analysis further confirmed the
successful preparation of the isomalathion stereoisomers. Both specific rotations
and 31 P NMR data of the individual isomalathion stereoisomers confirmed the
enantiomeric and diastereomeric relationships for their assigned phosphorus and
carbon configurations (Table 6).
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Figure 26. The Unit Cell of the Malathion-Strychnine Salt 53c.
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Figure 27. The structure of the 53c Anion of the Malathion-Strychnine Salt
as Determined by X-ray Crystallographic Analysis.
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Figure 28. Chiral HPLC Resolution of Isomalathion Stereoisomers.

Competing 0-alkylation to form malathion was detected by TLC in the
final alkylation step (approximately 10%). This 0-methylation also was observed
in the dealkylation/realkylation preparation of isomalathion using KSC(S)OEt and
dimethyl sulfate (Scheme 4).
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Table 6. Physical Data of the Isomalathion
Stereoisomers.a
31

compound

(a]D22

12a (JR,3R)

+42.3 (0.64)

58.38

12b (JR,3S)

-57.6 (0.50)

56.92

12c (JS,3R)

+58.6 (0.64)

56.92

12d (JS,3S)

-44.8 (0.58)

58.38

P NMR (8)

arotations performed in CHC1 3 ; concentrations
in parenthesis, g/100 ml.

It was assumed that the S-methylation did not disturb the phosphorus

configuration, thus, allowing the absolute configurations of the resulting
isomalathion stereoisomers to be known from the preceding alkaloid salts. While
this method provided the four stereoisomers of isomalathion and allowed
configurational assignment, there were two major disadvantages: (1) the yield of
the fractional crystallization was low (20% ), and (2) the process of fractional
crystallization was tedious and time consuming.

Consequently, an alternate

method was designed.

A Simplified Synthesis of Isomalathion Stereoisomers via Alkaloid Resolution
Since

the

diastereomeric

strychnine

salts

of

0,0,S-trimethyl

phosphorodithiolate (54) had been previously resolved (Hilgetag, 1969), it was
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believed that these salts could be used in a reaction with the triflate of diethyl
malate 39 (used in the chiral malathion synthesis) to provide the isomalathion
stereoisomers 12 (Scheme 8).

Using this approach, several steps could be

eliminated. Again, the design was convergent attempting to couple two resolved
chiral "pieces."
Resolution of the alkaloid salts 54a and 54b via fractional crystallization
(Hilgetag, 1969) was achieved readily and in a much greater yield than that of the
malathion alkaloid salts 53a, 53b, 53c, and 53d. The displacement of the triflate
that followed was also successful providing the isomalathion stereoisomers 12 in
an overall yield of 27 % from triflate 39, which exceeded the yield of the previous
method (11 % from triflate 39).
was monitored by melting point and specific rotation.

However, definitive

analysis as to the stereoisomeric purity of the salts could not be conveniently
determined by

31

P NMR as with the malathion-strychnine salts because of

overlapping 31 P NMR resonances. Therefore, the progress of the fractional
The progress of enrichment during fractional crystallization of the two
diastereomeric salts (54a and 54b) crystallization steps was monitored by specific
rotations and by reaction with a single enantiomer of the triflate (39a) followed
by 31 P NMR analysis of the product (isomalathion, 12a or 12c). It was found that
after three recrystallizations, a single stereoisomer of isomalathion could be
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1. strychnine
2. fractional
crystallization
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Scheme 8. Synthesis of Isomalathion Diastereomers via
Alkaloid Resolution: Method II.

obtained by reaction with 39a. The procedure was conducted with 39b to afford
the other two isomalathion stereoisomers (12b and 12d).
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Summary
The individual stereoisomers of malathion 6a/6b, malaoxon 22a/22b, and
isomalathion

12a/12b/12c/12d

have

been

successfully prepared

(>95%

stereoisomeric purity by HPLC analysis) and represent the first total synthesis of
these stereoisomers. The entries in Table 7 summarize salient physical data of the
individual stereoisomers as well as that for critical synthetic intermediates.
With the acquisition of the individual stereoisomers of malathion,
malaoxon, and isomalathion, the role of stereochemistry upon their interactions
with AChE is now permitted.

80

Table 7. Physical Data for Malathion, Malaoxon, lsomalathion
Stereoisomers, and Chiral Intermediates.
31

compound

P NMR (o)

mp (°C)

36a (S)-diethyl malate

- 5.45 (l.21)

36b (R)-diethyl malate

+ 5.23 (l.05)

39a (S)-triflate

+ 32.6 (1.39)

39a (R)-triflate

- 30.1 (l.71)

6a (R)-malathion

+ 79.7 (12.5)

96.15

6b (S)-malathion

- 80.0 (l.25)

96.15

22a (R)-malaoxon

+ 46.7 (0.55)

28.30

22b (S)-malaoxon

- 43.5 (0.75)

28.30

53a (JR,3R)-sa1t

+ 32.2 (0.25)

67.20

159-160

53b (JR,3S)-salt

- 45.1 (0.26)

68.12

189

53c (1 S,3R)-salt

+ 16.1 (0.31)

68.10

181-182

53d (JS,3S)-salt

- 61.7 (0.31)

67.18

158-159

54a (R)-salt

+ 15.8 (0.54)

78.87

202-203

54b (S)-salt

- 13.5 (0.63)

78.79

253

12a (JR,3R)-isomalathion

+ 42.3 (0.64)

58.38

12b (JR,3S)-isomalathion

- 57.6 (0.50)

56.92

12c (JS,3R)-isomalathion

+ 58.6 (0.64)

56.92

12d (1 S,3S)-isomalathion

- 44.8 (0.58)

58.38

arotations in CHC1 3 except 54 in MeOH; concentrations (g/lOOmL) in
parenthesis.

CHAPTER 4
RESULTS AND DISCUSSION: The Interactions of Malathion, Malaoxon,
and Isomalathion Stereoisomers with Acetylcholinesterase.

Biological Evaluation of Malathion Enantiomers
Two preparations of rat brain AChE (RBAChE; homogenized and
solubilized) were selected for stereoselective inhibition studies with the malathion
enantiomers (6a and 6b). The rationale behind this selection was that they were
observed to exhibit the greatest stereoselectivity during inhibition by isoparathion
methyl enantiomers (Ryu, 1991b). Unfortunately, malathion was such a weak
inhibitor of RBAChE that attempts to accurately determine the ki of the malathion
enantiomers were impeded due to the poor solubility of the compounds at the
concentrations needed to affect inhibition. As a result, no reliable data was
collected.
The differential toxicities of the malathion enantiomers, however, was
studied in collaboration with Cheminova (Lemvig, Denmark) using several insect
species. The most notable difference observed was with Drosophila Melanogaster
where the concentration of the R-enantiomer 6a needed to cause 50% mortality
(LD50) was 4-fold less than that of the S-enantiomer 6b (Figure 29) indicating that
the R-enantiomer 6a is more toxic to Drosophila Melanogaster.
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Figure 29. Media-Test of Malathion Enantiomers with Drosophila
Melanogaster.

Inhibition of AChE by Malaoxon Enantiomers
Since the 0,0-diethyl malaoxon stereoisomers 27a/27b showed a 4.4-fold
difference in anticholinesterase activity (Hassan, 1968), it was presumed that
similar stereoselectivity would be displayed by the 0,0-dimethyl stereoisomers

22a/22b. Results from previous investigations showed that among several sources
of AChE tested against isoparathion-methyl enantiomers 49a/49b RBAChE was
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83
the most stereoselective while human erythrocyte AChE (HEAChE) was the least
(Ryu, 1991).

Thus, it was desired to examine the stereoselective inhibition

profiles of these two cholinesterases against chiral malaoxon 22 to obtain an
understanding of the influence of a chiral carbon ligand. In order to evaluate the
inhibitory potency of the malaoxon stereoisomers and to compare them to the
differences observed for the 0,0-diethyl analogues (Hassan, 1968), the
bimolecular rate constants, ki, were first determined according to Eqn. 3 (Section
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Figure 30. Inhibition of RBAChE (Homogenized) by Malaoxon Enantiomers.
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1.8). Plots of ln(AJA 1) versus time provided curves with slopes proportional to
ki (Figure 30).

Table 8. Bimolecular Inhibition Rate Constants for
Malaoxon Enantiomers.
RBAChEa
kj
1
M· min· 1 (x 103)

HEAChEb
kj
1
M· min· 1 (xl0 3)

22a (R)

152

201

22 (RS)

101

97

22b (S)

30

48

compound

BEAChEc
kj
1
M· min· 1 (xl0 3)

malaoxon

0, 0-diethyl malaoxon

27a (R)

28.0

27 (RS)

14.9

27b (S)

6.3

ahomogenized, 25°C. b37°C. cbovine erythrocyte AChE (Hassan,
1968)

The ki values showed that (R)-malaoxon 22a was a 5.0-fold and a 4.2-fold
stronger inhibitor than (S)-malaoxon 22b of RBAChE and HEAChE, respectively
(Table 8).

In both cases, racemic material was found to be intermediate in

inhibitory strength. The stereoisomer preference and the 4-5-fold
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difference in potency is in good agreement with that reported by Hassan and
Dautermann (1968) and indicates that the change from diethoxy to dimethoxy did
not alter the interaction significantly.
To further understand the process of stereoselective inhibition by the
malaoxon stereoisomers, the partial kinetic parameters, i.e. the dissociation
constant (K0 ), and the phosphorylation constant (kp), were evaluated (Table 9)
according to Eqn. 2 (Section 1.8). In order to make useful comparisons to the
data obtained with chiral isoparathion methyl enantiomers (Ryu, 1991b),
solubilized RBAChE was examined. Plots of 1/[i] versus Lilnv/Lit provided Kv
as the inverse of the y-intercept while the slope of the curve is defined as k/Kv
or k; (Figure 31).
The data in Table 9 reveal that (R)-malaoxon 22a was an 8.6-fold more
potent anti-RBAChE agent (k;, reaction constant) than (S)-malaoxon 22b, which
represents a more significant difference than noted previously for homogenized
RBAChE. These results suggest that the stereochemistry of the succinyl carbon
was indeed important in the inhibition process and comparable with the 8.3-fold
inhibitory potency difference between the isoparathion methyl enantiomers
49a/49b.

The difference in inhibitory potency between the two malaoxon

enantiomers is further revealed by the dissociation constant K0 where the
formation of the Michaelis enzyme-inhibitor complex occurs 10-fold faster for
(R)-malaoxon 22a. Because enzymes provide an asymmetric environment, it
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Figure 31. Inhibition of RBAChE (Solubilized) by Malaoxon Enantiomers.

is not surpnsmg that stereoselective interactions occur with enantiomeric
inhibitors. Such stereoselectivity is further anticipated since certain conformations
attained by one stereoisomeric inhibitor that enhance the affinity for the active site
may not be attained by an inhibitor with the opposite configuration.
The difference in the phosphorylation constants,

~.

for the malaoxon

enantiomers was relatively small (1.4-fold) suggesting that the carbon stereocenter
was relatively less important in the phosphorylation step as compared to the
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Table 9. Kinetic Data for the Inhibition of RBAChE by Malaoxon
and lsoparathion Methyl Enantiomers. a
kbI
M- min- 1 (xl0 3)

Kv
mM (xl0-5)

kp
min- 1

22a (R)

731 (0.07)

44

0.316

22 (RS)

141 (0.09)

235

0.313

22b (S)

85 (0.09)

387

0.327

compound

1

malaoxon

isoparathion methylc

49a (S)

630 (0.08)

27

0.17

49 (RS)

410 (0.10)

45

0.19

49b (R)

78 (0.06)

273

0.21

acoefficient of variation in parentheses. bsolubilized, 37 °C. c(Ryu, 1991)

affinity for the active site (Table 9). If inhibition of AChE by malaoxon proceeds
through the loss of the thiosuccinyl ligand (Scheme 9), this small difference in the
~

is not surprising.
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Scheme 9. Proposed Mechanism for the Inhibition of AChE by Malaoxon.

Inhibition of AChE by Isomalathion Stereoisomers
Our studies with the malaoxon enantiomers showed that the ligand
stereocenter affects the inhibitor potency, and therefore prompted an inhibition
study of the isomalathion stereoisomers, which also bear a phosphorus asymmetric
center. Values for ki, K0 , and kP for the individual stereoisomers were determined
against two sources of the enzyme: solubilized RBAChE and electric eel AChE
(EEAChE). Solubilized RBAChE was selected in order to compare data from the
malaoxon enantiomer experiments. EEAChE was examined in order to observe
a possible species-dependent stereoselectivity for the isomalathion stereoisomers.
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Inhibition of RBAChE by Isomalathion Stereoisomers
Initially, inhibition of RBAChE by diastereomeric mixtures of isomalathion
with fixed carbon configurations (12ac 1RS,3R and 12bd JRS,3S; also known as
semi-racemates) was conducted in order to establish the contribution of the
asymmetric phosphorus toward inhibition. The kinetic parameters of inhibition
(ki, K0 , and kP) for RBAChE were determined as described for malaoxon using

Eqn 2 (Section 1.8). We found that (JRS,3R)-isomalathion 12ac was only a 3.0fold more potent inhibitor of RBAChE than (JRS,3S)-isomalathion 12bd (Table
10) suggesting that either RBAChE could not distinguish the carbon
configurational stereoisomers of isomalathion as well as it could with malaoxon,
or that the inhibition process may be complicated due to the presence of the
asymmetric phosphorus center. To more precisely address the stereoselective
inhibition of RBAChE, the inhibitory profiles for the individual stereoisomers of
isomalathion were determined as well (Figure 32, Table 10). In addition, an
86:14 mixture of (JS,3S)- and (JR,3R)-isomalathion obtained during the synthesis
of the stereoisomers was examined to evaluate the effect a weighted mixture of
inhibitors with differing potency had upon the overall inhibition profile of the
mixture (Table 10).
A 29-fold difference m anti-AChE potency was found between the
strongest (12a JR,3R) and weakest (12d JS,3S) inhibitor. The inhibitory potencies
(k) of the diastereomeric mixtures (JRS,3R- and JRS,3S-isomalathion) were found
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Figure 32. Inhibition of RBAChE by Isomalathion Stereoisomers.

to be midway between the respective antipodes, and the fully racemic material
gave an average ki value relative to the four stereoisomers. The 86: 14 mixture of
(12d:12a)-isomalathion reacted with RBAChE to give a ki value that closely
reflected the molar ratio of the individual stereoisomers according to the following
equation: [(% stereoisomer A) x (ki of stereoisomer A)] + [(% stereoisomer B) x
(ki of stereoisomer B)] = ki of the AB mixture (calculated= 59 x 103 ; found= 56
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Table 10. Inhibitory Kinetic Data for RBAChE
Inhibited by Isomalathion Stereoisomers.a
kb
Kn
M· min"1(xl0 3) mM(xl0"5)
I

1

stereoisomer

kp
min"1

12a (JR,3R)

347 (0.12)

55

0.192

12ac (JRS,3R)

260 (0.07)

66

0.170

12c (JS,3R)

81 (0.08)

670

0.533

12 (JRS,3RS)

132 (0.10)

298

0.380

12b (JR,3S)

105 (0.12)

188

0.189

12bd (JRS,3S)

86 (0.05)

414

0.353

12d (JS,3S)

12 (0.06)

20000

2.510

12d:12a (86:14)

56 (0.21)

440

0.233

asolubilized, 37
parentheses.

°c. bcoefficient of variation in

Both (JR,3R)- and (JR,3S)-isomalathion (12a and 12b) were more potent
inhibitors of RBAChE than the corresponding 1S-stereoisomers; a preference for
the (R)-configuration of the phosphorus atom was also noted for nerve gas agents
and methyl phosphonates, and was ascribed to specific complementary active site
features (Jarv, 1984; Benschop, 1988; Berman and Decker, 1989; Berman and
Leonard, 1989). In addition, isomalathion stereoisomers with the (3R)-carbon
configuration displayed greater inhibitory potency against RBAChE than those
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with the (JS)-configuration at carbon. Yet, the impact on the inhibition reaction
by the carbon stereocenter was further attenuated by the configuration at
phosphorus. For example, the difference in inhibitory strength associated with a
change in the carbon configuration from R to S was 6.8-fold when the phosphorus
configuration was S, while the difference was only 3.3-fold when the phosphorus
configuration was R. Likewise, the effect of the phosphorus stereocenter was
leveraged by the carbon stereocenter. This effect is evidenced by a comparison
of the 1S and 1R stereoisomers, which gave a 4.3-fold ki difference when the
carbon configuration was R, while the difference was 8.8-fold when the carbon
configuration was S. Therefore, the carbon and phosphorus asymmetric centers
of isomalathion act interdependently during inhibition of RBAChE.
Values for K0 and kP were determined for the isomalathion stereoisomers
(Table 10). As with the malaoxon stereoisomers, the ki values paralleled the
dissociation constants, K0 , where the isomer with the greater affinity for the active
site was the stronger inhibitor. For example, (JR,JR)-isomalathion 12a displayed
a 3.4-fold stronger affinity for the active site than (JR,JS)-isomalathion 12b (or
weaker dissociation from the active site) and was a 3.3-fold stronger inhibitor.
However, based solely upon the K 0 values, (JR,3S)-isomalathion 12b was
expected to be a 100-fold stronger inhibitor than (1 S,JS)-isomalathion 12d rather
than the observed 8.8-fold difference. The unusual magnitude of kP (2.510) for
the 1S,3S isomer partially compensated for the poor affinity (K0 = 20,000) toward
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the active site.
The kP values obtained for inhibition of RBAChE by 12a and 12b were
virtually identical, consistent with the results obtained with malaoxon. However,
kP values for 12c and 12d differed by 4.7-fold, and were significantly higher than

those for 12a and 12b. Thus, the carbon stereochemistry significantly influenced
the phosphorylation only when (JS,3R)- or (JS,3S)-isomalathion were the
inhibitors, and suggested that the thiosuccinyl ligand remains attached (Scheme
10, Path B). Conversely, since there was no difference in the kP for (JR,3R)- and
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(JR,3S)-isomalathion, it is likely that the thiosuccinyl ligand is displaced and has
little stereochemical influence over this step (Scheme 10, Path A). Alternatively,
if RBAChE inhibition by the four isomalathion stereoisomers occurs via a
common mechanism (i.e. displacement of the thiosuccinyl ligand with inversion
of the phosphorus configuration (Berman and Decker, 1989) then the putative (S)or (R)-0,S-dimethylphosphorothiolated AChE would result.

Thus, the two

phosphorylated enzymes resulting from inhibition by the isomalathion
stereoisomers should be identical to RBAChE inhibited by (S)- or (R)-isoparathion
methyl (loss of p-nitrophenoxy; Scheme 11).

Inhibition of EEAChE by Isomalathion Stereoisomers
In order to identify any possible species-dependent variation in the
stereoselectivity (Lee, 1978; Wallace, 1991) inhibition of EEAChE by the
isomalathion stereoisomers also was investigated. Further, the X-ray structure of
EEAChE was recently published (Sussman, 1991), which may permit more
precise calculations of active site complementarity to be conducted.
The kinetic parameters (ki, K 0 , and kP) for the inhibition of EEAChE by
isomalathion stereoisomers were determined experimentally using Eqn. 2 (Section
1.8) (Figure 33, Table 11). The results of these experiments show that differences
between the weakest ((JR,3S)-isomalathion 12b) and strongest ((JS,3R)isomalathion 12c) inhibitor was only 13-fold compared to the 29-fold difference
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Figure 33. Inhibition of EEA ChE by lsomalathion Stereoisomers.

found for RBAChE. That EEAChE discriminates less between the isomalathion
stereoisomers was not unexpected since species-dependent, stereoselective
inhibition against varying sources of AChE was observed for the enantiomers of
fonofos oxon (Lee, 1978). For example, the fonofos oxon enantiomers are
discriminated 5-fold better by mouse brain cholinesterase than EEAChE.
Isomalathion stereoisomers with the R-carbon configuration were stronger
inhibitors of EEAChE than the isomalathion stereoisomers with the S
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configuration, and the inhibitory strength due to the carbon configuration was
again attenuated by the configuration at phosphorus but to a lesser degree than
with RBAChE. For example, (JS,3R)-isomalathion 12c was a 3.9-fold stronger
inhibitor than (1 S,3S)-isomalathion 12d as compared to the 6.8-fold difference
found against RBAChE. The difference in ki between (JR,3R)- and (JR,3S)isomalathion was only 2.3-fold compared to the 3.3-fold for
RBAChE. The most striking result found for the inhibition of EEAChE was that

Table 11. Kinetic Dataa for the Inhibition of EEAChE
by Isomalathion Stereoisomers.

isomalathion

ki
Kn
1
3
M" min" (xl0 ) mM(x10"5)
1

kp
min·1

12a (JR,3R)

57 (0.04)

70

0.040

12b (JR,3S)

25 (0.09)

138

0.034

12c (1S,3R)

333 (0.07)

1330

4.590

12d (JS,3S)

85 (0.04)

3670

3.070

3

Coefficient of variation in parenthesis

the (1 S)-isomalathion stereoisomers were stronger inhibitors than the (1 R)isomalathion stereoisomers; the inverse of the RBAChE inhibitor stereoselectivity.
Thus, a species-dependent, stereoselective inhibition by isomalathion was
observed for RBAChE and EEAChE not only in the extent that the enzymes
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could discriminate between configurations, but also in the inhibitory strength of
one configuration versus another.
Although (1 R)-isomalathion stereoisomers had a significantly greater
affinity (K0 ) for the EEAChE active site by approximately 20-fold, the (1 S)isomalathion stereoisomers were more potent inhibitors. However, the difference
in the affinity was compensated for and further dominated by the magnitude of
kP for (1 S,3R)- and (1 S,JS)-isomalathion, revealing another facet of the "inteiplay

between occupation of the active center and productivity of that occupation
(Berman and Leonard, 1989b). " Unlike the stereoisomers which differ only by
their phosphorus configuration, those with the same phosphorus configuration
show a correlation between the relative inhibitory potency (ki) and the K0 . For
example, the difference in ki between (1 S,3R)- and (1 S,JS)-isomalathion was 3.9fold while the difference in K0 was 2.8-fold. In addition, the difference in ki
between the (JR,3R)- and (JR,JS)-isomalathion was 2.3-fold while the difference
in K 0 was 2.0-fold.
As with RBAChE, the kP values were identical for the JR,3R and JR,3S
stereoisomers, consistent with a mechanism where the asymmetric carbon center
contributes little to the phosphorylation step (Scheme 10, Path A). The EEAChE
kP values for (JS,3R)- and (JS,JS)-isomalathion differ by 1.5-fold.

Since we

observed that EEAChE shows less discrimination than RBAChE during inhibition
by isomalathion stereoisomers, the 1.5-fold difference compared to the 4.7-fold
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difference in kP for RBAChE was not surprising. That the thiosuccinyl ligand
stereochemistry is significant at all in the phosphorylation step suggests that a
similar mechanistic switch to that proposed for RBAChE (Scheme 10, Path B)
may also occur with EEAChE.

Reactivation of RBAChE Inhibited by Isomalathion Stereoisomers
If, indeed, the mechanisms of inhibition of RBAChE by isomalathion and

isoparathion methyl are convergent as suggested in the conclusion of Section 4.4.,
then the reactivation profiles of RBAChE inhibited by these two compounds
should be comparable. In an effort to clarify any mechanistic ambiguity and to
distinguish the influence of stereochemistry upon the recovery processes, the rate
constants of spontaneous and oxime-mediated reactivation (k0 and koxime; Eqns. 4
and 5, Section 1.9 and 1.10) were determined.
RBAChE was inhibited by each isomalathion stereoisomer (and the 86:14
(JS,3S/JR,3R mixture), followed by a 40-fold dilution to halt further inhibition.

The spontaneous reactivation rate constants, k0 (Eqn. 4, Section 1.9.) were
calculated from the slope of the initial portion (0-30 min.) of the graphs plotted
by In( JOO/%inhibition) vs. time (Figure 34, Table 12).
Rate constants for oxime-mediated reactivation (koxime) were determined
similarly.

Following inhibition of RBAChE by each of the isomalathion

stereoisomers and the 40-fold dilution, the enzyme was reacted with 2-pyridine
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Figure 34. Spontaneous Reactivation of RBAChE Inhibited by Isomalathion
Stereoisomers.

aldoxime methiodide (2-PAM). The oxime-mediated rate constants,

koxime

(Eqn.

5, Section 1.10.) were calculated from the initial slope of the graphs plotted by

ln( JOO/%inhibition) vs. time (Figure 35, Table 12).
By 60 minutes, the reactivation (spontaneous and oxime-mediated) reached
a plateau and was assigned the total percent reactivation relative to uninhibited
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Table 12. Reactivation Dataa for RBAChE Inhibited by Isomalathion
and Isoparathion Methyl Enantiomers.

kob
% spontaneous
koxime e
% oxime
min-1(xl0"3) reactivationc min" 1(x10"3)reactivationd

isomer

isomalathion
12a (JR,3R)

13.7 (0.03)

42 (0.13)

51.0 (0.05)

81 (0.09)

12b (JR,3S)

12.5 (0.03)

38 (0.05)

50.8 (0.05)

81 (0.10)

12c (JS,3R)

0

<1

1.9 (0.04)

9 (0.14)

12d (JS,3S)

0

<1

0

2 (0.01)

8.6 (0.01)

29 (0.04)

39.3 (0.12)

66 (0.12)

12d:12a (86:14)

isoparathion
49a (S)

11.3 (O.lOY

49 (RS)

10.2 (O.lOY

49b (R)

3.5 {0.04)e

50.2 (0.02)

13.8 (0.17)

acoefficient of variation in parentheses bcorrelation coefficient (c.c.) >
0.99 where applicable. cafter 60 min. dc.c. > 0.99 except 12c where c.c.
= 0.49. e (Thompson, 1993).

enzyme (Table 12). In all instances, no additional enzyme activity returned after
120 min.
The

koxime

values for RBAChE inhibited by (JR,3R)- or (JR,3S)-

isomalathion were 4-fold greater than the spontaneous reactivation (k0 ) values.
The total percent returned enzyme activity was twice that of the spontaneous
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Figure 35. Oxime-Mediated Reactivation of RBAChE Inhibited by
Isomalathion Stereoisomers.

process.

Both the spontaneous (approximately 13 x 10-3 min- 1) and oxime-

mediated reactivation (approximately 51 x 10-3 min- 1) rates for these two
diastereomers were nearly identical suggesting that the resultant phosphorylated
enzymes were chemically and stereochemically equivalent.
In contrast, RBAChE inhibited by (1 S,3R)- or (1 S,3S)-isomalathion were
refractory to either spontaneous or oxime-mediated reactivation and showed only
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a modest amount of total returned activity (<10%) following treatment with
oxime. The minor rate of reactivation detected was probably due to background
oxime based hydrolysis of acetylthiocholine (control shows 6% hydrolysis) or a
1-3% contamination by the enantiomer, which is a far superior inhibitor that can
undergo reactivation.
The results of spontaneous and oxime-mediated reactivation from RBAChE
by the 86: 14 (12d:12a) enantiomer mixture strongly correlated with (JR)isomalathion stereoisomer kinetics (Figure 33 and 34). From this mixture, the
mole fraction of the inhibited species was calculated to be 18% inhibited by 12d
and 82% inhibited by 12a.

All reactivation observed for the mixture was

attributed to RBAChE inhibited by 12a since inhibition of RBAChE by 12d was
refractory to reactivation. The reactivation rate values were calculated from the
corresponding mole fractions as 10.7 x 10-3min- 1 for k0 and 41.6 x 10-3 min- 1 for
k0 xime• which are in excellent agreement with the observed values of 8.6 x 10-3
min- 1 and 39.3 x 10-3 min- 1• Although 12a composed only 14% of the doped
mixture, it dominated the molar fraction of the inhibited enzyme owing to its
greater inhibitory potency (ki value).

These results signify and augment the

importance of stereoisomer purity in an evaluation of biological activity.
Some intriguing mechanistic implications can be surmised when the
spontaneous and oxime-mediated reactivation rates are compared for RBAChE
inhibited by isomalathion and isoparathion methyl stereoisomers (Thompson,
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1993).

The reactivation rates from (JR,3R)- and (JR,3S)-isomalathion

(spontaneous, approximately 13 x 10-3 min- 1 ; oxime-mediated, approximately 51
X 10-3 min-I), and (S)-isoparathion methyl (SpOntaneOUS, 11.3 X 10-3 min-I; OXimemediated, 50.2 x 10-3 min- 1) were comparable supporting a common mechanism
of inhibition, namely, ejection of the thiosuccinyl or p-nitrophenoxy leaving
groups, respectively, to give (R)-0,S-dimethyl phosphorothiolated RBAChE
(Scheme 11 ). Although the process of phosphorylation described in Scheme 11
occurs with inversion, the phosphorus configuration remains R for the (JR)isomalathion diastereomers.
Conversely, RBAChE inhibited by (1 S,3R)- and (1 S,3S)-isomalathion
showed negligible reactivation compared to the slow but observable rates from
(R)-isoparathion methyl 49b inhibited RBAChE (spontaneous, 3.5 x 10-3; oximemediated, 13.8 x 10-3 min- 1). One explanation for this anomaly is that inhibition
of RBAChE by (1 S,3R)- or (1 S,3S)-isomalathion results in an inhibited enzyme
that is different than the O,S-dimethylphosphorothiolated species, namely, the loss
of the thiomethyl group (Scheme 10, Path B). Diminished attention was given
to the possibility that the methoxide ligand was displaced during phosphorylation
since the thiomethyl group was shown to be the preferred leaving group during
AChE inhibition by methamidophos (Scheme 12; Thompson, 1982).

It is

noteworthy that this mechanistic switch is linked to the configuration at
phosphorus. The hypothesis that the mechanisms of RBAChE inhibition differ

105

0

II

0

II
__ P,
CH30

/

"'scHs

H2N

55 m ethamidophos

/p--

o" \
AChE ,_

I

OCH3

NH2

~AChE

Scheme 12. Mechanism for the Inhibition of AChE by Methamidophos.

for (JS,3R)- and (JS,3S)-isomalathion from (JR,3R)- and (JR,3S)-isomalathion is
unexpected since the displacement of the thiosuccinyl ligand has long been
accepted as the conventional phosphorylation mechanism (Clothier, 1981).
Following inhibition of RBAChE by (1 S,3R)- or (1 S,3S)-isomalathion, a chiral
thiosuccinyl ligand was still attached to the enzyme and differences in reactivation
rates (spontaneous or oxime mediated) due to the configuration of carbon were
expected. Although rate differences have been observed for oxime mediated
reactivation of AChE inhibited with a phosphoryl group bearing a second
asymmetric center (soman) (DeJong, 1985a,b), essentially no reactivation
following inhibition by either of the two (1 S)-isomalathion diastereomers was
observed, and an explanation of this phenomenon was warranted.
Several postinhibitory processes are possible following RBAChE inhibition
by either of the two (JS)-isomalathion stereoisomers including: (a) displacement
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of the thiosuccinyl ligand via a general base catalyzed mechanism (Scheme 13,
Path A), (b) intramolecular phosphorylation by a second enzyme nucleophile
(Scheme 13, Path B), (c) B-elimination of diethyl fumarate or diethyl maleate
(Scheme 13, Path C), or (d) reduced approach of incoming nucleophiles (H20,
oxime) owing to steric crowding enforced by the thiosuccinyl ligand (not shown).
If the succinyl thiolester-phosphorus bond is cleaved by the action of water or

oxime, the remaining phosphoryl group would become charged and therefore
unsuitable for reactivation by nucleophiles (Scheme 13, Path A). Diminished
reactivation rates due to steric crowding has been documented in a study that

Scheme 13. Proposed Non-Reactivatable Pathway for {JS)-Isomalathion.
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showed that the reactivation of dimethyl phosphorylated AChE was faster than
diethyl phosphorylated, while diisopropyl phosphorylated AChE did not reactivate
(Cassida, 1956). The B-elimination (Scheme 13, Path C) process may occur via
a general base type mechanism, which has its foundation in the methoxidepromoted B-elimination of malathion (Bhagwat, 1974; Figure 16, Section 2.1.).
Moreover, the ejection of acrolein from hydroxylated cyclophosphamide follows
a similar

~-elimination

mechanism (Connors, 1975).

Non-Reactivation of RBAChE Inhibited by lsoparathion Methyl Enantiomers:
A Model Study
Although RBAChE inhibited by the (JR)-isomalathion diastereomers
reactivated as expected, RBAChE inhibited by the (1 S)-isomalathion diastereomers
showed no reactivation. Thus, an examination of the significance of phosphorus
(or carbon) stereochemistry upon the time dependent loss of the enzyme's ability
to reactivate, i.e., non-reactivatability, is precluded by those results.

If the

mechanism of inhibition of RBAChE by all of the isomalathion stereoisomers
occurred as initially expected (loss of the thiosuccinyl moiety, Scheme 11), then
the influence of stereochemistry upon the non-reactivatability of O,Sdimethylphosphorothiolated RBAChE (provided only by the (JR)-diastereomers)
could be examined. In an effort to obtain results for such an event, RBAChE
inhibited by isoparathion methyl was examined since it would provide the putative
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stereoisomers of O,S-dimethylphosphorothiolated RBAChE (Scheme 11).
Furthermore, such a study would serve as a model for RBAChE inhibited by the
S-methyl isomerides of other dimethyl phosphorothionate insecticides.
RBAChE was incubated with the individual stereoisomers of isoparathion
methyl for 20 min to afford approximately 90% inhibition.

The incubation

mixtures were then diluted 40-fold to halt the inhibition and at time intervals
following the dilution, 2 aliquots were withdrawn to: (1) determine the activity
that returned via spontaneous reactivation and (2) to determine the total amount
of activity that could be restored. The second determination was executed by
reacting the aliquot with 2-PAM for 20 min.

The rate constants for

nonreactivatability (kNR) were determined (Table 13) from slopes of graphs
(Figure 36) plotted using the following equation:

where A,-A/ = (activity of the reactivated enzyme with oxime at time = t) (activity of the inhibited enzyme without oxime at time= t) and A 0 -A 0 ' =(activity
of the reactivated enzyme with oxime at time = 0) - (activity of the inhibited
enzyme without oxime at time= 0).
RBAChE inhibited by (R)-isoparathion methyl underwent a rate of nonreactivation approximately twice that of the (S)-stereoisomer confirming the
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significance of phosphorus stereochemistry with regard to non-reactivation
pathways. This result is not entirely surprising since RBAChE inhibited by (R)isoparathion methyl reactivated approximately 3.5-fold slower than the antipode
(Table 12) allowing for greater competition of non-reactivating processes.
Noteworthy is the fact that RBAChE inhibited by racemic isoparathion methyl
underwent non-reactivatability at a rate essentially identical to that of RBAChE
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Figure 36. Non-reactivatability ofRBAChE inhibited by IsoparathionMethyl
Enantiomers.

llO

inhibited by (S)-isoparathion. This result also was not surprising since the mole
ratio of the enzyme inhibited by (S)-isoparathion methyl resulting from the
incubation with the racemic mixture, was approximately 8-fold greater than that
of enzyme inhibited by (R)-isoparathion methyl (Table 9). Thus, it was expected

Table 13. Non-Reactivatability of
RBAChE Inhibited by Isoparathion
Methyl Stereoisomers.
isoparathion methyl kNRa (min· 1 x 10-1)

s

1.42 (0.09)

RS

1.37 (0.04)

R

3.07 (0.10)

acoefficient of variation in parenthesis.

that the (S)-stereoisomer would dominate the non-reactivatability profile of
RBAChE inhibited by racemic isoparathion methyl because 8 times as much (S)inhibited RBAChE was available for reactivation.

Conclusions
Malaoxon.

In conclusion, a significant stereoselective inhibition of AChE by the
malaoxon enantiomers was uncovered whereby RBAChE showed greater

lll

sensitivity to carbon asymmetry than bovine erythrocyte AChE did for 0,0diethyl malaoxon (Hassan, 1968).

Furthermore, this sensitivity of RBAChE

toward the carbon asymmetry of malaoxon was as great as that toward the
phosphorus stereochemistry of isoparathion methyl (Ryu, 1991 b).

Isomalathion.

An interdependence between both asymmetric centers (phosphorus and
carbon) of the isomalathion stereoisomers was identified for the inhibition of
RBAChE, and to a lesser extent, EEAChE. In addition, a species-dependent
stereoselectivity was observed between RBAChE and EEAChE whereby the
difference in inhibitory strength between the stereoisomers was greater for
RBAChE than EEAChE.

More importantly, the (JS,3R)- and (JS,3S)-

isomalathion stereoisomers were weaker inhibitors of RBAChE but surprisingly
stronger inhibitors of EEAChE resulting from an interdependence between
stereoisomer affinity (K0 ) for the EEAChE active site and the fecundity (kp) of
that affinity.
The reactivation profiles of RBAChE inhibited by the isomalathion
stereoisomers along with the results from the inhibition experiments support a
mechanistic switch for the inhibition of RBAChE from the expected thiosuccinyl
displacement to loss of the thiomethyl ligand for (1 S,3R)- and (1 S,3S)isomalathion and predicts the same for EEAChE based upon phosphorylation
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constants (kP). As a consequence, a non-reactivatable pathway is postulated for
RBAChE inhibited by (1 S,3R)- and (1 S,3S)-isomalathion.
Although isomalathion could provide only one phosphorus configuration
of O,S-dimethylphosphorothiolated RBAChE due to the mechanistic switch linked
to the phosphorus stereochemistry, isoparathion methyl could furnish both
configurations and thus provided a model for RBAChE inhibited by each
configuration. Consequently, the results of the non-reactivation study indicated
that phosphorus stereochemistry was significant (although less than for inhibition
and reactivation) for post-inhibitory processes leading to non-reactivatable
enzyme.

CHAPTER 5
SUMMARY

The individual stereoisomers of malathion, malaoxon, and isomalathion
have been successfully prepared and as a result represent the first preparation of
these stereoisomers.

Two methods for the preparation of the isomalathion

stereoisomers were developed, each offering distinct advantages.
Differential toxicities of the malathion enantiomers were identified for
Drosophila Melanogaster showing (R)-malathion to be a 4-fold stronger

insecticide.

Detailed anti-AChE profiles (ki, K 0 , and kP) for the malaoxon

enantiomers were determined demonstrating that (R)-malaoxon was a 8-fold
stronger inhibitor than its antipode. Inhibition constants (ki, K 0 , and kP) for the
isomalathion stereoisomers against RBAChE and EEAChE also were determined
resulting in an apparent interdependence between both asymmetric centers
(phosphorus and carbon) of the isomalathion stereoisomers for the inhibition of
RBAChE, and to a lesser extent, EEAChE. Furthermore, a species-dependent
stereoselectivity was observed between RBAChE and EEAChE.
The reactivation profiles (k0 and kP) of RBAChE inhibited by the
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isomalathion stereoisomers were determined and support a mechanistic switch for
the inhibition of RBAChE from the expected thiosuccinyl displacement to loss of
the thiomethyl ligand for (1 S,3R)- and (1 S,3S)-isomalathion and predict the same
for EEAChE based upon phosphorylation constants (kp).
Results from a non-reactivation study using isoparathion methyl
enantiomers to provide stereochemically opposed forms of O,S-dimethyl
phosphorylated AChE, indicated that phosphorus stereochemistry was significant
(although less than for inhibition and reactivation) for post-inhibitory processes
leading to non-reactivatable enzyme.

CHAPTER6
FUTURE WORK

Stereoselective Detoxication and Bioactivation of Malathion Stereoisomers
The preparation of the individual stereoisomers of malathion 6, malaoxon

22, and isomalathion 12 has allowed the viability of investigations concerning the
role of the stereochemistry of these compounds upon the relevant metabolism and
action of these compounds.

For example, the stereoselectivity of malathion

detoxication by mammalian carboxylesterases could be examined in an effort to
identify differential in vivo lifetimes of the malathion enantiomers. In addition,
the stereoselective activation of the malathion enantiomers to the corresponding
malaoxon enantiomers by oxidizing enzymes should be examined.

Stereoselective Inhibition of Carboxylesterase by Malaoxon and
Isomalathion Stereoisomers
The stereoselective inhibition of rat liver carboxylesterase by 0,0-diethyl
malaoxon enantiomers 27 had been previously examined (Hassan, 1968) where
an 8.3-fold difference in inhibitory potency was observed for the antipodes.
However, the stereoselective inhibition of the malaoxon enantiomers 22 has been
115
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left undiscovered.

Because the potentiation of malathion toxicity has been

attributed to the isomalathion 12 content through inhibition of carboxylesterase,
the stereoselective inhibition of this enzyme by isomalathion should be examined
and the results compared to the corresponding anti-AChE potency of the
individual stereoisomers. Such a study would provide a better understanding of
the toxicological profiles of each stereoisomer and aid identification of the
contributions of each isomalathion stereoisomer to the overall toxicity of a
racemic mixture. Acquisition of malaoxon and isomalathion stereoisomers now
allows such investigations to be completed.

Mechanistic Switch for UR)- and (JS)-lsomalathion
In order to support the apparent mechanistic difference for the inhibition
of RBAChE by the (1 R)- and (1 S)-isomalathion stereoisomers, compounds that
would result in the same thiosuccinyl-linked phosphorodithiolated RBAChE such
as 56b/56d (Figure 37) could be reacted with RBAChE and the corresponding
reactivation profiles determined and compared to those of RBAChE inhibited by
(1 S)-isomalathion diastereomers. The thionate analog 57 of 56 is also interesting

as a potential insecticide possessing a carbethoxy portion susceptible to
detoxication by carboxylesterases in addition to two potential leaving groups
following bioactivation to 57.
14

CH 3S-isomalathion stereoisomers 58 should be prepared and reacted with

117

Figure 37. Mechanistic Probes for RBAChE Inhibition by Isomalathion.
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RBAChE to examine the possible mechanistic switches proposed for the (JR)- and
(1 S)-stereoisomers. If a switch does indeed occur, then the label will remain on

the enzyme for the (JR)-stereoisomers (58ac) while RBAChE inhibited by the
(1 S)-stereoisomers (58bd) would be devoid of the label if the S-methyl ligand was

displaced.

B-Elimination of RBAChE Inhibited by (1 S)-Isomalathion
To further examine the B-elimination proposed for RBAChE inhibited by
the (1 S)-isomalathion stereoisomers, inhibitors with structures prone to this
elimination (Figure 38; 59, 60, 61) should be devised and examined for similar
reactivation profiles. Analogues that may be less prone to this type of elimination

(62, 63, 64) should also be considered in an effort to examine the possibility of
steric hinderance as a cause for the recalcitrant behavior toward reactivation of
RBAChE inhibited by (1 S)-isomalathion stereoisomers.

In parallel chemical

studies, elimination should be examined in the presence of base and compared to
those rates observed for the decomposition of malathion and malaoxon (Bhagwat,
1974).
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Stereoselective Inhibition and Reactivation of Other AChE's with the
Isomalathion Stereoisomers
To determine possible species-dependent stereoselective inhibition of AChE
by the isomalathion stereoisomers, other sources of AChE should be examined.
As indicated in Section 4.5, a significant alteration of the inhibitory profile of the
isomalathion stereoisomers for EEAChE compared to RBAChE has been
identified. Furthermore, an examination of the reactivation profiles of EEAChE
(as well as other AChE sources) inhibited by the isomalathion stereoisomers may
reveal novel species-dependent reactivation or species-dependent mechanisms of
isomalathion-mediated inhibition (i.e., loss of the thiosuccinyl or thiomethyl
ligand).

Molecular Docking Studies
With the recent availability of the X-ray structure of EEAChE (Sussman,
1991; Maelicke, 1991), differences observed for the dissociation constants (K0 )
of the isomalathion stereoisomers may be correlated with structural data of the
EEAChE active site by using molecular docking studies.

Enantioenriched O,S-Dimethyl Phosphorothiolating Reagent
The resolved strychnine-dithioate salts prepared for use in the procurement
of the isomalathion stereoisomers have been invaluable. Specifically, the O,S-
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Scheme 14. Chiral Phosphorylating Agents.

dimethyl phosphorodithioate salts proved to be a convenient means to
synthetically introduce the chiral O,S-dimethyl phosphorodithiolate moiety. To
make this method more accessible, less toxic resolving agents may be considered
such as phenethylamine, ephedrine or quinine. Furthermore, conversion of these
salts to the asymmetric thiophosphoryl chloride (Scheme 14; 67) in an analogous
fashion to which the methyl p-nitrophenyl phosphorochloridothionate enantiomers
(66) were prepared (Hirashima, 1983) may provide useful for introducing the
enantioenriched O,S-dimethyl thiolthionophosphoryl moieties onto a nucleophilic
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center. Stereoselective oxidative desulfuration of 67b to 68b with MMPP or mCPBA may provide a more reactive analogue for introducing the O,S-dimethyl
thiolophosphoryl moiety onto a nucleophilic center.

CHAPTER 7
EXPERIMENTAL

General
Commercially available reagents were purchased from Aldrich
Chemical Co., Milwaukee, WI. All solvents and reagents were purified when
necessary by standard literature methods. Melting points were determined on a
Fisher-Johns melting point apparatus.

Analytical thin-layer chromatography

(TLC) was conducted on E. Merck aluminum-backed, 0.2 mm silica gel 60 F254 ,
TLC plates. Flash chromatography was performed with K.ieselgel 60, 230-400
mesh (Merck). Elemental analyses were performed by Midwest Microlab Ltd.,
Indianapolis, IN.
Proton {1H), carbon {1 3C), and phosphorus (3 1P) NMR spectra were
recorded on a Varian VXR 300-NMR instrument in deuterated chloroform
(CDC1 3) unless specified otherwise. Pertinent proton frequencies are tabulated in
the following order: chemical shift (Ci in ppm), multiplicity (s, singlet; d, doublet;
t, triplet; q, quartet; m, multiplet), coupling constant (J in hertz), and the number
of hydrogens. Proton and carbon frequencies of spectra obtained are relative to
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chloroform (1H, 7.24 ppm; 13 C, 77.0 ppm) as an internal standard unless specified
otherwise. Phosphorus chemical shifts are relative to phosphoric acid (H 3P04 ) in
CDC1 3 as an external standard.
High-performance liquid chromatography (HPLC) was performed using an
ABI (Analytical Kratos Division, Ramsey, NJ) series 400 Spectroflow pump and
a Spectroflow 783 programmable absorbance variable wavelength detector
equipped with a flow cell of 8.0 nm in path length and 12 µL in dead volume.
All results from the UV visible detector (215 nm, sensitivity range 0.1 AUFS)
were recorded by a Hewlett Packard 3396A integrator (Avondale, PA). Injections
were made by a Rheodyne 7125 injector (Bodman Chemical, Aston, PA) fitted
with a 20 µL sample loop. Separation and purity detection were performed on a
25 cm x 4.6 mm i.d. Chiralpak AD (Regis Chemical Company, Morton Grove,
IL) analytical column. Isopropyl alcohol and hexane used (mobile phase) were
analytical grade and were purchased from Bodman Chemical, Aston, PA (EM
Science). The mobile phase was degassed prior to use by sonication with a
Bransonic Model 32 (A. Daigger Scientific, Wheeling, IL). Elution was isocratic.

Synthesis
(S)-Diethyl malate (36a) was prepared as described previously (Cohen,
1966) from (S)-malic acid. [a] 0 24 = -5.45° (c = 1.21, CHC1 3).
(t, J = 7.2, 3H), 1.31 (t, J

1

H NMR

o 1.27

= 7.2, 3H), 2.75-2.90 (m, 2H), 4.18 (q, J = 7.1, 2H),
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4.28 (q, J = 7.2, 2H), 4.49 (t, J = 5.3, lH).

C NMR

o 14.02, 38.66, 60.89,

61.91, 67.23, 170.44, 173.30.

(R)-Diethyl malate (36b) was prepared as described previously (Cohen,
1966) from (R)-malic acid. [a] 0 24 =+5.23° (c

= 1.05, CHC1

3).

The NMR spectra

data of this material were identical to that of 36a.

(S)-0-(p-Toluenesulfonyl)-diethyl malate (37a) was prepared ( 2.96 g,
82%) as described generally in a previous report (Kabalka, 1986) starting with
(S)-diethyl malate (2.00 g, 10.5 mmol). [a] 0 22
NMR

= -43.4° (c = 0.615, CHC1

3).

1

H

o 1.17 (t, J = 7.1, 6H), 2.41 (s, 3H), 2.86 (d, J = 5.9, 2H), 4.05 (dq, J =

2.9, 7.1, 2H), 4.11 (q, J
7.78 (d, J = 8.4, 2H).

13

= 7.3, 2H), 5.19 (t, J = 5.9,
C NMR

lH), 7.31 (d, J

= 8.6, 2H),

o 13.9, 14.0, 21.7, 37.3, 61.2, 62.1, 73.7, 128.0,

129.6, 133.2, 144.9, 167.3, 168.0.

(S)-0-(Methanesulfonyl)-diethyl malate (38a). To a stirring solution of
(S)-diethyl malate (0.200 g, 1.05 mmol) in CH 2Cl 2 (2 mL, 0°C) under an Ar<g>
atmosphere was added methanesulfonyl chloride (0.12 mL, 1.57 mmol) followed
by the addition of TEA (0.15 mL, 1.05 mmol). After 15 min, the reaction was
complete as indicated by TLC and the mixture was partitioned between 20 mL
10% HCl and 20 mL ethyl ether. The aqueous layer was extracted with 20 mL
ethyl ether and the organic layers were combined, washed with 20 mL brine,
dried over sodium sulfate and rotary evaporated to give a colorless oil (0.257 g,
81 %. [a] 0 22

= -23.9° (c = 0.640, CHC1

3).

1

H NMR

o 1.24 (t, J = 7.2, 3H), 1.28
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(t, J = 7.1, 3H), 2.92-2.94 (m, 2H), 3.14 (s, 3H), 4.16 (q, J = 7.1, 2H), 4.25 (dq,
J

= 1.9, 7.1, 2H), 5.33 (dd, J =5.1, 6.9, lH).

13

C NMR o 14.0, 14.1, 37.0, 39.0,

61.4, 62.4, 73.9, 167.7, 168.4.

(S)-0-(Trifluoromethanesulfonyl)-diethyl

malate

(39a).

Trifluoromethanesufonic anhydride (2.00 mL, 11.9 mmol) was dissolved in 10 mL
CH2Cl2 under an Ar(g) and chilled to -78 °C. (S)-Diethylmalate (2.00 g, 10.6
mmol) was dissolved in 10 mL CH 2Cl 2 to which 2,6-lutidine (1.24 mL, 10.6
mmol) was added. This mixture was added dropwise to the anhydride over 15
min. After the addition was complete, the reaction mixture was brought to 0 °c
for 1 hand then allowed to warm slowly to room temperature until TLC indicated
the consumption of (S)-diethylmalate (2 h).

The reaction mixture was

concentrated to an oil followed by addition of ethyl ether to precipitate the
lutidinium salt that was filtered in vacuo and washed 3 times with 50 mL ethyl
ether. The filtrate was rotary concentrated to an oil (3.47 g, 100% crude yield)
and used immediately in the conversion to (R)-malathion. [a] 0 25 = +32.6° (c =
I.39, cHC1 3).

1

H NMRo 1.29 (t, 1

= 1.2, 3H), 1.34 (t, 1 = 1.2, 3H), 3.06 (d, 1

= 5.7, 2H), 4.22 (dq, J = 2.1, 7.2, 2H), 4.33 (dq, J = 2.1, 7.2, 2H), 5.49 (t, J =
6.0, lH).

13

C NMR o 13.79, 13.92, 36.81, 61.82, 63.17, 78.80, 112.45, 116.23,

120.47, 124.70, 166.03, 167.52.

(R)-0-(Trifluoromethanesulfonyl)-diethyl malate (39b) was prepared as
indicated above for (S)-0-(trifluoromethanesulfonyl)-diethylmalate starting with
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(R)-diethylmalate. [a] 0 25

= -30.1° (c = 1.71, CHC1 3).

The NMR spectral data

were identical to that of 39a.

Sodium 0,0-dimethylphosphorodithioate (34) was prepared from
neutralizing 0,0-dimethylphosphorodithioic acid with sodium carbonate in
methanol. Following filtration and concentration of the solvent, crystallization
was induced with ethyl ether. 0,0-dimethylphosphorodithioic acid was prepared
as described previously (Kabachnik, 1953; Toia, 1980). 1H NMR
14.4).

13

C NMR

o52.76, 52.85.

31

P NMR

o3.43 (d, J =

o 117.6.

(R)-Malathion (6a). Crude (S)-0-(trifluoromethanesulfonyl)-diethylmalate
(3.47 g) was dissolved in 20 mL THF and chilled to 0 °c under Ar<g> atmosphere.
Sodium 0,0-dimethylphosphorodithioate (2.86 g, 15.9 mmol) was dissolved in
10 mL THF and added dropwise to the triflate solution over 15 min. The reaction
mixture was allowed to warm slowly to room temperature until TLC indicated the
consumption of starting material (2 h). The reaction mixture was partitioned
between 50 mL ethyl ether and 50 mL water. The aqueous layer was extracted
with 50 mL ether, the organic layers combined, extracted with brine, dried over
sodium sulfate, and rotary evaporated. Purification via flash chromatography gave
a colorless oil (2.79 g, 80% yield). Rf= 0.20 (petroleum ether, ethyl ether, 1:1).
[a] 240 = +79.7° (c = 1.25, CHC1 3 ).

1

H NMR

o 1.22 (t, J = 7.2, 3H), 1.25 (t, J =

7.2, 3H), 2.84 (dd, J = 5.4, 17.1, lH), 3.00 (dd, J = 9.0, 17.1, lH), 3.77 (dd, J =
3.0, 15.3, 6H), 4.03-4.22 (m, SH).

13

C NMR: 0 13.9, 14.0, 37.7, 37.8, 44.98,
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45.03, 54.21, 54.27, 61.08, 62.04, 169.90, 169.99. 31 P NMR:

o96.15.

(S)-Malathion 6b was prepared as previously described for (R)-malathion
starting with (R)-0-(trifluoromethanesulfonyl)-diethylmalate. [a.]270 = -80.0° (c
= 1.25, CHC1 3). The NMR spectra data of this material was identical to that of

6a.

(RS)-Malathion (6) was prepared as described previously from diethyl
maleate (Mallipudi, 1980).
(R)-Malaoxon (22a). Method A. (R)-Malathion (0.200 g, 0.606 mmol)
was dissolved in 3 mL CH 2Cl 2 and added to a stirring suspension of technical
grade (80%) monoperoxyphthalic acid magnesium salt (MMPP, 0.187 g, 0.606
mmol) in 2 mL CH 2Cl 2 • The mixture was brought to reflux for 24 h afterwhich
it was concentrated and partitioned between 20 mL ethyl ether and 20 mL
saturated aqueous sodium bicarbonate. The aqueous layer was extracted with 20
mL ether, the organic layers combined, extracted with brine, dried over sodium
sulfate, and concentrated to an oil. Purification via flash chromatography gave
a colorless oil (0.098 g, 52% yield).

Rr = 0.13 (petroleum ether, ethyl ether, 1:2

volume ratio). Method B. (R)-Malathion was converted to (R)-malaoxon (25%
yield) as described for racemic material (Bellet, 1974).

[a.] 25 0

= +46.7° (c =

0.555, CHCl3). 1H NMR: 0 1.23 (t, J = 7.0, 3H), 1.27 (t, J = 7.0, 3H), 2.90 (dd,
J = 5.4, 17.1, lH), 3.06 (dd, J = 8.7, 17.1, lH), 3.81 (dd, J = 4.8, 12.9, 6H), 4.08-

4.24 (m, 5H).

13

C NMR: 0 13.91, 14.03, 38.11, 38.18, 42.38, 42.43, 54.07,
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54.14, 54.22, 61.06, 62.09, 169.84, 170.00, 170.08.

31

P NMR: 0 28.3.

(S)-Malaoxon (22b) was prepared as indicated for (R)-malaoxon starting
with (S)-malathion. [a] 27 0 = -43.5° (c = 0.75, CHC1 3).
(RS)-Malaoxon (22) was prepared as indicated for (R)-malaoxon starting
with (RS)-malathion.
(JRS,3R)-lsomalathion (12ac) was prepared from (R)-malathion via the
dealkylation-realkylation sequence previously reported (Thompson, 1989). [a] 270

= +41.3° (c = 1.25, CHC13).
(JRS,3S)-Isomalathion (12bd) was prepared from (S)-malathion via the
dealkylation-realkylation sequence as previously reported (Thompson, 1989).
[a] 270 = -40.0° (c = 0.75, CHC1 3).

(JRS,3RS)-Isomalathion (12) was prepared from (RS)-malathion via the
dealkylation-realkylation sequence as previously reported (Thompson, 1989).
(

13

CH3S)-(JRS,3RS)-Isomalathion (12') was prepared from (RS)-malathion

via the dealkylation-realkylation sequence as previously reported (Thompson,
1989) by substituting (13CH 30) 2S0 2 for (CH 30) 2S0 2 •
S-Methyl phosphorodichloridate (47). Thiophosphoryl chloride (21.12
g, 0.125 mol) was dissolved in 75 mL benzene (0 °C) followed by the addition
of CaO (14 g), acridine (90 mg), and methanol (7.5 mL). The reaction mixture
was allowed to warm slowly to room temperature, and after 3.5 h, the mixture
was filtered and the product (0-methylthiophosphoryl chloride) was distilled (20
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mm Hg, 45 °C).

The distillate was isomerized by heating the 0-

methylthiophosphoryl chloride at 100 °c for 20 h as described previously
(Hilgetag, 1969) after which the product, S-methyl phosphorodichloridate, was
distilled in vacuo at 60 °C.

1

H NMR:

o 2.64 (d, J = 23.1).

N-(Ethyl prolinyl) S-methyl chlorophosphoramidothiolate (50).

S-

Methylphosphorochloridate (0.98 g, 5.94 mmol) was dissolved in 7.5 mL benzene
and a solution of ethylprolinate (0.85 g, 5.94 mmol) and TEA (0.82 mL, 5.94
mmol) was added dropwise over 15 min. The reaction was stopped after 1 h.
Following separation and purification by flash chromatography, colorless oils were
obtained for the two diastereomers. Rr = 0.42, 0.30 (ethyl ether).

Fast Band. [a] 0 24

= -52.6° (c = 1.04, CHC1

1

H NMR:

3).

o 1.28 (t, J =

7.1, 3H), 1.95-2.30 (m, 4H), 2.50 (d, J = 18.2, 3H), 3.38-3.46 (m, 2H), 4.19 (q,
J

= 7.1, 2H), 4.48 (dt, J = 3.6, 8.1,

lH).

Slow Band. [a] 0 24 = -48.2° (c
3H), 1.98-2.29 (m, 2H), 2.40 (d, J

31

P NMR: O 37.71.

= 1.15, CHC1

3 ).

= 18.0, 3H), 3.51

J = 1.8, 7.2, 2H), 4.35 (dt, J = 3.3, 8.5, lH).

31

1

H NMR: 1.30 (t, J

(q, J

P NMR:

=7.2,

= 6.6, 2H), 4.21

(dq,

o 38.05.

(S)-Diethylmercaptosuccinate (Sla). (R)-Diethyl bromosuccinate (0.5 g,
1.98 mmol), prepared as described previously (Hassan, 1968) was dissolved in 2.0
mL acetone (0 °C). Sodium hydrosulfide (0.142 g, 2.5 mmol) was dissolved in
1 mL water and diluted to 2 mL with acetone. The sodium hydrosulfide solution
was added to the diethyl bromosuccinate solution, and after 2 h, the acetone was
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removed by rotary evaporation and the product was extracted from the water with
ethyl ether and further purified by distillation (lmm Hg, 55 °C) using a Kugelrhor
apparatus to give a colorless oil (0.18 g, 44% ). [a] 0 26 = -19 .1° (c = 1.6, CHC1 3).
1

H NMR: 0 1.22 (t, J = 7.1, 3H), 1.26 (t, J = 7.1, 3H), 2.16 (d, J = 9.4, lH), 2.71

(dd, J

= 6.0, 16.9, lH), 2.96 (dd, J = 9.0, 16.9, lH), 3.70 (dt, J = 6.0, 9.3,

4.12 (q, J = 7.1, 2H), 4.18 (q, J = 7.1, 2H).

13

C NMR:

lH),

o 14.08, 14.21, 36.33,

36.96, 61.02, 61.77, 170.14, 172.13.

(RS)-Diethyl mercaptosuccinate (51) was prepared as described for
diethyl malate starting with mercaptosuccinic acid (Ailman, 1965). This material
was purified as described above for (R)-diethyl mercaptosuccinate.

S-(1,2-Dicarbethoxy)ethyl

S-methyl

N-(ethyl

prolinyl)

phosphoramidodithiolate (52). The fast band of 50 (0.10 g, 3.68 mmol) was
dissolved in 0.5 mL THF (freshly distilled) followed by the addition of
diethylmercaptosuccinate (0.083 g, 4.05 mmol) and TEA (0.056 g, 4.05 mmol)
and allowed to stir under an Ar<g> atmosphere for 20 h. The reaction mixture was
filtered and purified via flash chromatography to give a colorless oil (0.056 g,
34.5%). Rf= 0.27 (ethyl ether). [a] 0 24 = -48.0° (c = 1.24, CHC1 3).

1

H NMR:

o 1.22-1.32 (m, 9H), 1.94-2.23 (m, 4H), 2.37 (dd, J = 1.2, 15.3, 3H), 3.09-3.15
(m, 2H), 3.43-3.51 (m, 2H), 4.10-4.46 (m, 8H). P NMR: o47.52, 48.12.
31

Strychnine-(3R)-isomalathion salt (53a, 53c). (R)-Malathion (2.0 g, 6.06
mmol) was dissolved in 30 mL methanol, strychnine (2.23 g, 6.66 mmol) was
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added, and the mixture brought to reflux for 16 h. The solvent was evaporated
and the waxy solid was taken up in 25 mL chloroform. Ethyl acetate (480 mL)
was added followed by 70 mL ether. The solution was heated to effect solution
and stored at 0 °C. After 4 days, the first crop of crystals was filtered and
washed with 75 mL ethyl ether. Ethyl ether (125 mL) was added to the filtrate,
which was permitted to stand at room temperature for 2 days, after which the
flocculent second crop of crystals was filtered and washed with 50 mL ethyl
ether. By
enrichment.

31

P NMR, the first crop (53c, JS,3R) showed 72% diastereomeric
The second crop (53a, JR,3R) showed 100% diastereomeric

enrichment. The first crop was recrystallized by dissolving 1.65 g in 99 mL
methanol to which 594 mL ethyl ether was added.

31

P NMR of the resulting

crystals showed 93% enrichment. Final recrystallization of these crystals (SpRc)
to 100% enrichment was achieved by dissolving 1.37 g in 80 mL methanol
followed by the addition of 320 mL ethyl ether. Data for 53a: mp= 159-160°C.
[a] 0 24 = +32.2° (c = 0.25,CHC13).

1

H NMR: cS 1.18 (t, J = 7.1, 3H), 1.19 (t, J

= 7.1, 3H), 1.38 (dt, J = 2.9, 10.5, lH), 1.67 (d, J = 15.4, lH), 2.17 (dd, J = 5.1,
13.3, lH), 2.33 (dt, J = 6.8, 13.9, lH), 2.68 (dd, J = 2.8, 17.7, lH), 2.95-3.18 (m,
4H), 3.35 (s, lH), 3.62 (d, J = 15.0, 3H), 3.84 (s, 4H), 4.00-4.17 (m, 8H), 4.214.35 (m, 2H), 4.43 (d, J = 13.l, 3H), 6.59 (s, lH), 7.15 (t, J = 7.5, lH), 7.31 (t,
J = 7.8, lH), 7.50 (d, J = 7.1, lH), 8.07 (d, J = 8.0, lH).

13

C NMR: cS 14.20,

14.24, 25.29, 29.75, 38.53, 39.70, 42.10, 44.43, 44.47, 47.11, 53.20, 53.39, 53.48,
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55.82, 58.82, 60.65, 61.25, 61.16, 64.24, 64.32, 75.09, 116.52, 122.59, 124.82,
127.76, 130.16, 132.77, 136.67, 141.67, 166.65, 171.03, 171.42, 171.50.
NMR:

o 67.20.

Jlp

Anal. Calcd for C 31 H41 N20 8PS 2 : C, 56.01; H, 6.22; N, 4.21.

Found: C, 56.26; H, 6.23; N, 4.32. Data for 53c: mp = 181-182°C. [a] 0 22 =
+16.1° (c = 0.31, CHC13). 1H NMR:
1.38 (dt, J

= 2.8, 10.5, lH),

o1.18 (t, J =7.2, 3H), 1.20 (t, J =7.1, 3H),

1.69 (d, J

= 16.1,

lH), 2.17 (dd, J

= 4.6, 14.2, lH),

2.33 (dt, J = 7.3, 13.6, lH), 2.68 (dd, J = 2.8, 17.7, lH), 2.95-3.18 (m, 4H), 3.34
(s, lH), 3.62 (d, J = 14.9, 3H), 3.83 (s, 4H), 4.00-4.20 (m, 8H), 4.21-4.49 (m,
5H), 6.57 (s, lH), 7.15 (t, J
lH), 8.08 (d, J = 8.0, lH).

13

= 7.7,

lH), 7.32 (t, J

C NMR:

= 7.4,

lH), 7.50 (d, J

= 7.1,

o14.19, 14.24, 25.30, 29.76, 38.62, 38.65,

39.68, 42.11, 44.40, 44.44, 47.08, 53.22, 53.41, 53.50, 55.87, 55.91, 58.81, 60.66,
61.27, 61.84, 61.88, 64.23, 64.38, 64.42, 75.13, 116.56, 122.54, 124.87, 127.68,
130.22, 132.73, 136.74, 141.68, 168.63, 171.08, 171.66.

31

P NMR:

o68.10.

Strychnine-(3S)-isomalathion salt (53b, 53d). (S)-Malathion (2.0, 6.06
mmol) was dissolved in 30 mL methanol, strychnine (2.23 g, 6.66 mmol) was
added, and the mixture refluxed for 16 h. The solvent was evaporated and the
waxy solid was taken up in a minimum of methanol followed by addition of 300
mL ethyl acetate and 100 mL ethyl ether. The solution was heated to reflux and
allowed to cool to r.t. The first crop of crystals was filtered and washed with 120
mL ethyl ether. The filtrate was allowed to stand at room temperature and the

second crop of crystals were filtered and washed with ethyl ether. By 31 P NMR,
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the first crop (53b, JR,3S) showed 71 % diastereomeric enrichment. The second
crop (53d., JS,3S) showed 100% diastereomeric enrichment. The first crop was
recrystallized by dissolving 1.032 g in 62 mL methanol to which 372 mL ethyl
ether was added. The resulting crystals showed 86% enrichment by 31 P NMR.
These crystals (2.460 g) were dissolved in 150 mL of methanol followed by the
addition of 750 mL ethyl ether giving crystals of 94% enrichment.

Final

recrystallization of these crystals to 100% enrichment was achieved by dissolving
1.100 g in 33 mL ethylene glycol and 55 mL absolute ethanol followed by the
addition of 495 mL ethyl ether. Data for 53b: mp= 189° C. [a] 0 24 = -45.1° (c
= 0.26, CHCl3) 1H NMR: 0 1.17 (t, J = 7.1, 3H), 1.19 (t, J = 6.9, 3H), 1.37 (d,
J = 10.5, lH), 1.66 (d, J = 15.6, lH), 2.18 (dd, J = 5.5, 14.3, lH), 2.33 (dt, J =

7.0, 13.9, lH), 2.67 (dd, J = 2.7, 17.8, lH), 2.94-3.17 (m, 4H), 3.34 (s, lH), 3.60
(d, 14.9, 3H), 3.81 (s, 4H), 4.01-4.13 (m, 8H), 4.20-4.42 (m, 5H), 6.55 (s, lH),
7.14 (t, J = 7.5, lH), 7.30 (t, J = 7.4, lH), 7.51 (d, J = 7.3, lH), 8.06 (d, J = 8.0,
lH).

13

C NMR o 14.17, 14.23, 25.29, 29.74, 38.60, 38.63, 39.67, 42.08, 44.39,

44.43, 47.07, 53.21, 53.39, 53.48, 55.86, 58.80, 60.66, 61.26, 61.86, 64.22, 64.38,
75.08, 116.52, 122.59, 124.85, 127.72, 130.17, 132.75, 136.69, 141.66, 168.63,
171.06, 171.63. 31 PNMRo68.12. Datafor53d: mp= 158-159°C. [a] 0 22 =
-61.7 (c = 0.31, CHC1 3). 1H NMR o 1.18 (t, J = 7.1, 6H), 1.37 (d, J = 10.3, lH),
1.66 (d, J = 15.1, lH), 2.16 (dd, J = 5.4, 13.1, lH), 2.27-2.38 (m, lH), 2.68 (dd,
J = 2.7, 17.8, lH), 2.93-3.17 (m, 4H), 3.34 (s, lH), 3.62 (d, J = 15.1, 3H), 3.83
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(s, 4H), 4.01-4.18 (m, 8H), 4.21-4.33 (m, 2H), 4.43 (s, 3H), 6.58 (s, lH), 7.14 (t,
J = 7.4, lH), 7.31 (t, J = 7.8, lH), 7.52 (d, J = 7.4, lH), 8.07 (d, J = 7.9, lH).
13

C NMR:

o14.17, 14.23, 25.34, 29.72, 38.50, 39.67, 42.06, 44.45, 44.49, 47.10,

53.20, 53.39, 53.48, 55.78, 55.80, 58.81, 60.65, 61.28, 61.81, 64.23, 74.99,
116.48, 122.64, 124.81, 127.81, 130.12, 132.80, 136.64, 141.65, 168.66, 171.02,
171.43.

31

P NMR:

o 67.18.

0,0,S-trimethylphosphorodithioate (23) was prepared from as described
previously (Umetsu, 1977).

Strychnine-0,0,S-trimethylphosphorodithioate

Salt

(54).

This

procedure has been reported previously (Hilgetag, 1969) but is repeated here with
slight modifications. Strychnine (24.40 g, 0.0730 mol) was added to a stirring
solution of 0,0,S-trimethylphosphorodithioate in methanol (180 mL).

The

reaction mixture was brought to reflux for 24 h. Upon cooling, the first crop of
crystals (54a, R) precipitated and was filtered, washed with methanol, and
recrystallized twice from methanol. Data for 54a: mp= 202-203° C. [a.] 0 22 =
+15.8° (c = 0.545, MeOH).

1

H NMR:

o 1.38 (dt, J = 3.1, 10.7,

lH), 1.56 (d, J

= 14.8, lH), 1.97 (d, J = 2.8, lH), 2.02 (d, J = 14.1, 3H), 2.14 (dt, J = 7.6, 13.7,
lH), 2.44-2.59 (m, 2H), 2.97 (dd, J = 8.2, 17.8, lH), 3.27 (s, 3H), 3.30 (s, lH),
3.44 (d, J = 14.6, 3H), 3.56-3.76 (m, 3H), 3.95-4.25 (m, 5H), 4.35 (dt, J = 3.2,
8.3, lH), 6.28 (s, lH), 7.12 (t, J = 7.6, lH), 7.25 (t, J = 7.7, lH), 7.37 (d, 7.6,
lH), 7.78 (d, 8.1, lH).

13

C NMR:

o 13.53,

13.58, 24.18, 28.87, 38.82, 40.68,
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46.03, 48.83, 52.82, 53.09, 53.18, 54.40, 58.39, 61.63, 63.78, 64.10, 74.71, 76.36,
115.82, 122.94, 125.43, 129.08, 129.93, 132.68, 135.60, 140.65, 171.32.
NMR:

o78.87.

31

P

The mother liquor was stored at 0 °c and gave a second crop that

was recrystallized in 95% ethanol. The mother liquor was concentrated in vacuo
to a solid and recrystallized in 95% ethanol to give a third crop of crystals. The
second and third crop were combined and recrystallized once more in 95%
ethanol (54b, S). Data for 54b: mp= 253° C. [a] 0 22 = -13.5° (c = 0.63, MeOH).
1

H NMR: 0 1.36 (d, J = 10.7, lH), 1.55 (d, J = 15.7, lH), 1.91 (d, J = 12.2, lH),

2.01 (d, J = 14.1, 3H), 2.12 (dt, J = 7.8, 13.7, lH), 2.44-2.57 (m, 2H), 2.96 (dd,
J = 8.2, 18.1, lH), 3.27 (s, 4H), 3.44 (d, J = 14.5, 3H), 3.53-3.76 (m, 3H), 3.93-

4.25 (m, 5H), 4.34 (dt, J = 3.1, 8.3, lH), 6.28 (s, lH), 7.12 (t, J = 7.6, IH), 7.24
(t, J = 7.6, lH), 7.36 (d, J = 7.6, lH), 7.76 (d, J = 8.1, lH).

13

C NMR:

o 13.56,

13.60, 24.21, 28.89, 38.84, 40.72, 46.06, 52.83, 53.11, 53.20, 54.44, 58.40, 61.63,
63.80, 64.10, 74.72, 76.36, 115.83, 122.98, 125.45, 129.09, 129.95, 132.67,
135.63, 140.66, 171.29.

31

P NMR:

o78.79.

General Procedure for the Stereoisomers of Isomalathion (12) from
Strychnine-isomalathion Salt (53).

To a 0.12 M stirring solution of 12 in

methanol:acetone (1 :3), 1 equiv of dimethyl sulfate was added and the solution
was brought to reflux for 3 h, afterwhich 3 mL ethyl ether was added to
precipitate the sulfate salt. The reaction mixture was filtered, concentrated to an
oil and purified via flash chromatography (petroleum ether:ethyl ether; 1:2) to
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give a colorless oil.

General Procedure for the Preparation of Isomalathion Stereoisomers
(12a,12b,12c,12d) from Strychnine-0,0,S-trimethylphosphorodithioate salt
(54). To a 0.2 M stirring suspension of 54 in CH3CN was added 1 equiv of a
0.78 M solution of 39 in CH3CN dropwise over 5 min. After 1 h, the solution
was diluted two fold with ethyl ether to precipitate the strychninium triflate salt
and the mixture was filtered in vacuo. The filtrate was concentrated in vacuo to
an oil and purified by gravity chromatography (petroleum ether: ethyl ether; 1: 1)
to give the respective stereoisomer of 12 as a colorless oil.

(JR,3R)-lsomalathion (12a). Prepared from 53a (0.313 g, 0.471 mmol)
to give 12a (0.098 g, 63%). [a] 0 22 = +43.6° (c 0.55, CHC13). Prepared from 54b
(1.10 g, 2.17 mmol) and 39a (0.700 g, 0.217 mmol) to give 12a (0.220 g, 31 %).
[a] 0 22 = 42.3° (c 0.64, CHC1 3).

1

H NMR:

o 1.23 (t, J = 7.1, 3H), 1.27 (t, J = 7.1,

3H), 2.36 (d, J = 16.9, 3H), 2.97 (dd, J = 5.2, 17.2, lH), 3.08 (dd, J = 8.9, 17.1,
lH), 3.84 (d, J = 13.6, 3H), 4.08-4.25 (m, 5H).

13

C NMR: 0 13.38, 13.43, 13.98,

14.08, 38.16, 38.21, 43.24, 43.27, 53.83, 53.93, 61.12, 62.18, 169.93, 170.01.
NMR:

Jlp

o 58.38.
(JR,3S)-Isomalathion (12b). Prepared from 53b (0.200 g, 0.301 mmol)

to give 12b (0.066 g, 66%). [a] 0 22 = -64.3° (c 0.59, CHC1 3). Prepared from 54b
(1.57 g, 3.11 mmol) and 39b (l.00 g, 3.11 mmol) to give 12b (0.612 g, 60%).
[a] 0 22 = -57.6° (c 0.50, CHC1 3).

1

H NMR:

o 1.23 (t, J = 7.1, 3H), 1.27 (t, J =
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7.1, 3H), 2.37 (d, J = 16.8, 3H), 2.94 (dd, J = 5.2, 17.1, lH), 3.08 (dd, J = 8.8,
17.1, lH), 3.85 (d, J = 13.7, 3H), 4.09-4.26 (m, SH).

13

C NMR: 0 13.13, 13.17,

13.96, 14.07, 37.97, 38.02, 43.35, 43.40, 54.00, 54.11, 61.11, 62.18, 169.89.
NMR:

31

P

o 56.92.
(JS,3R)-Isomalathion (12c). Prepared from 53c (0.313, 0.471 mmol) to

give 12c (0.122 g, 79%). [a] 0 22 = +57.5° (c 0.57, CHC1 3). Prepared from 54a
(1.10 g, 2.17 mmol) and 39a (0.700 g, 2.17 mmol) to give 54a (0.178 g, 25%).
[a] 0

22

= +58.6° (c 0.64, CHC1 3). The NMR spectral data of this material was

identical to that of 12b.
(1 S,3S)-isomalathion (12d). Prepared from 53d (0.300 g, 0.452 mmol) to

give 12d (0.107 g, 72%). [a] 0 22 = -34.2 (c 0.59, CHC1 3). Prepared from 54a
(1.57 g, 3.11 mmol) and 39b (1.0 g, 3.11 mmol) to give 12d (0.523 g, 51 %).
[a] 0 22 = -44.8 (c 0.58, CHC1 3). The NMR spectral data of this material was

identical to that of 12a.

Assay of Anti-cholinesterase Potency
Determination of k; (time dependent).

Of an appropriately diluted solubilized rat brain AChE (approximating an
acetylthiocholine hydrolysis rate of 0.100 Abs. units/min), 1.09 mL was
withdrawn and placed in a test tube and transferred to a Forma-Scientific constant
temperature shaker bath set at 37 °c. To each of six cuvettes was added 2.5 mL
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of DTNB solution (3.33 x 10-3 M 5,5' -dithiobis(2-nitrobenzoic acid (DTNB) and
5.9 x 104 M sodium bicarbonate in pH 7.6 phosphate buffer) and 0.020 mL
acetylthiocholine iodide (ATCh-I) solution (7 .5 x 10-3 M in pH 7 .6 phosphate
buffer) and these cuvettes were placed in a Beckman DU-40 spectrophotometer
equipped with a kinetic Soft-Pac module. From the test tube of AChE solution,
0.10 mL was withdrawn and added to cuvette 1 to serve as a control. To the
remaining 0.990 mL in the test tube, 0.100 mL of an inhibitor solution was added
and the enzyme solution vortexed. At 3, 6, 9, 12, and 15 min, 0.100 mL of the
enzyme-inhibitor solution was added to cuvettes 2, 3, 4, 5, and 6, respectively.
The rate of hydrolysis was monitored at 412 nm at 30-s intervals for 15 min from
the addition of the enzyme. The bimolecular inhibition rate constant (k;) was
determined (in triplicate) using the following equation as defined previously
(Aldridge, 1950):

where A 0 represents the initial activity of the enzyme (time t = 0), A, represents
the depressed enzyme activity at time = t following the addition of the inhibitor
[i].

Determination of k;, Kv, and kP (concentration dependence).
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Five of test tubes containing suitably diluted AChE solution (0.490 mL)
were each treated with 0.010 mL of a progression of inhibitor concentrations. A
sixth test tube was treated with 0.010 mL of methanol to serve as control. The
inhibition was permitted to progress for 20 min, and the remaining enzyme
activity was determined as described above (A) over a period of 15 min (30-s
intervals). The bimolecular reaction constant (k), dissociation constant (KD), and
phosphorylation constant (kP) were determined using the following equation as
defined previously (Main, 1964):

ll[i] = (lit I Afnv)k; - l!Kv

where Llt

= 20

mm, .Lllnv

= ln(AofA

20 ),

and k;

= k/KD.

Assays involving

solubilized rat brain AChE and electric eel AChE were performed similarly except
that the solutions were made with pH 7.6 and pH 8.0 phosphate buffer,
respectively.

Spontaneous Reactivation
Solubilized rat brain AChE (0.20 mL) and 0.80 mL of 0.1 M phosphate
buffer (pH 7.6) were added to each of two test tubes. A 0.010-mL inhibitor
solution that caused 90% inhibition was added to the first tube and incubated in
a shaker bath at 37 °c for 20 min. Synchronously, MeOH (0.010 mL) was added
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to the second tube as a control and placed in the bath for 20 min. Following
inhibition, the first tube was further diluted with 40 mL of phosphate buffer (pH
7.6) to halt inhibition (t = 0 min), and 1 mL was withdrawn and placed in a
cuvette containing 1.5 mL of 5,5' -dithiobis(2-nitrobenzoic acid) (DTNB) solution
(3.33 x 104 M DTNB and 5.9 x 104 M NaHC0 3 in pH 7.6 phosphate buffer) and
0.020 mL of acetylthiocholine iodide (ATCh-I) solution (7.5 x 10-3 Min pH 7.6
phosphate buffer) to determine the remaining enzyme activity (A 0 ) while the
remainder of the solution was returned to the bath. The second tube was diluted
with 40 mL of phosphate buffer (pH 7.6), and 1 mL of the diluted solution was
placed in a second cuvette containing the solutions described above to determine
the initial enzyme activity (A, control). At subsequent 4-min intervals, 1 mL was
withdrawn from the remaining diluted solution of tube 1 and the enzyme activity
(A,) determined.

The rate constant for spontaneous reactivation (k0 ) was

calculated from the linear portion of the graph (0-32 min) using the following
equation:

In ( 1001 % inhibition)

where % inhibition = lOO[(A - A,)l(A - A 0 )].

= krJ
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Oxime-Mediated Reactivation
Solubilized rat brain AChE (0.20 mL) and 0.80 mL of phosphate buffer
(pH 7 .6) were placed in each of two test tubes, and the identical procedure to
spontaneous reactivation was followed.

Following dilution with 40 mL of

phosphate buffer (pH 7 .6), 1 mL was withdrawn from the first tube and the
remaining enzyme activity determined (A 0 ). Immediately following, 2-pyridine
aldoxime methiodide (2-PAM; 0.20 mL; 1.0 x 10-2 M) was added to the diluted
solution and the enzyme mixture returned to the water bath. The point at which
oxime was added was considered reactivation time t = 0. The second tube was
diluted with 40 mL of buffer and assayed for activity (AJ The rate constant for
oxime-mediated reactivation (koxime) was calculated from the linear portion of the
graph (0-10 min) using the following equation:

In ( 100/ % inhibition) =

where % inhibition

= lOO[(A - At)l(A - A

koximet

0 )].

After 10 min had elapsed, the enzyme was assayed at 10-min intervals to
determine the returned enzyme activity and the total% reactivation after 60 min.
Total % reactivation was calculated using the following equation:
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total % reactivation= 100 - (% inhibition at 60 min).

Non-Reactivatability
Rat brain AChE stock solution (0.20 mL) was diluted to 1.0 mL with
phosphate buffer (pH 7.6) and incubated for 20 min with inhibitor to produce
approximately 10-15% residual activity. Following the inhibition, the sample was
diluted with 40 rnL of phosphate buffer (t = 0), and at regular time intervals, 1rnL aliquots were withdrawn and added to a 1.52-rnL solution containing DTNB
and ATCh-1 as noted previously to determine the enzyme activity that returned
via spontaneous reactivation over the time course of this experiment.
Concurrently, 2-rnL aliquots were withdrawn and reacted with

1,1 ' -

trimethylenebis(4-formylpyridinium bromide) dioxime (TMB-4) (0.010 mL; 2.0
x 10-3 M) or 2-PAM for 20 min. The enzyme activity was evaluated as described
above to determine the amount of returned activity from oxime-mediated
reactivation. The rate constants of non-reactivatability (kNR) were calculated from
the linear portion of the graphs (20-60 min) according to the following equation:

2.3 log [(A 1 - A/)l(A 0 - A 0 ')]

= -kNRt

where A 1 - A/ = (activity of the reactivated enzyme with oxime at time = t) -
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(activity of the inhibited enzyme without oxime at time = t) and A 0

-

A0 ' =

(activity of reactivated enzyme with oxime at time = 0) - (activity of inhibited
enzyme without oxime at time = 0).

APPENDIX A
ENZYME INHIBITION ANALYSIS PROGRAM
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1000
1100
1200
1300
1400
1500
1600
1700
1800
1900
1950
2000
2100
2200
2250
2300
2400
2500
2600
2700
2800
2900
3000
3100
3200
3300
3400
3500
3600
3700
3800
3900
4000
4100
4200
4300

' KI .... AN ENZYME INHIBITION ANALYSIS PROGRAM
' Determination of Bimolecular Inhibition Rate Constants "ki"
'
Written by Clifford E. Berkman 8/24/90f
'
This program was written using equations from:
'INTRODUCTION TO BIOSTATISTICS by Sokal and Rohlf
'
{ pages 237, 247 272 }
'For GWBASIC
'******* ENTER TIME POINTS following Time= 0 *******
'
CLS: PRINT "DETERMINATION OF ki"
DIM X(IOO): DIM Y(IOO): DIM A(IOO)
PRINT: INPUT: "Name of inhibitor compound: ",INHIB$
PRINT: INPUT: "Inhibitor concentration (M): ",INHIBCONC
PRINT: INPUT: "This is Run #: ",R: CLS
PRINT: INPUT: "Number of cuvettes = ",N
PRINT "Cuvette # 1 :": PRINT "Time (min)= ";O
INPUT "Activity (rate)= ",AO: PRINT
FOR C=l to N-1
PRINT "Cuvette #";C+l;":": INPUT "Time (min)= ",X(C)
INPUT "Activity (rate) = ",A(C): PRINT
Y(C)=LOG(AO/A(C))
SUMX=SUMX + X(C)
SUMY=SUMY + Y(C)
SUMXY=SUMXY + X(C)*Y(C)
NEXT C
XMEAN=SUMX/(N-1)
YMEAN=SUMY/(N-1)
SUMPRODXY=SUMXY-SUMX*SUMY/(N-1)
FOR C=l TO N-1
SUMSQRX=SUMSQRX + (X(C)-XMEAN)"2
SUMSQRY=SUMSQRY + (Y(C)-YMEAN)"2
NEXT C
SLOPE=SUMPRODXY/SUMSQRX
INTERCEPT=YMEAN - SLOPE*XMEAN
CORRELCOEFF=SUMPRODXY/(SUMSQRX*SUMSQRY)".5
STDDEVSLOPE=(((SUMSQRY-SUMPRODXY"2/SUMSQRX)/3)
/SUMSQRX)" .5
4400 Kl=SLOPE/INHIBCONC
4500 CLS: LPRINT: LPRINT: LPRINT
4600 LPRINT TAB(IO); "Bimolecular Inhibition Rate Constant Determination:
'ki'"
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4700
4800
4900
5000
5100
5200
5300
5400
5500
5600
5700
5800
5900
6000
6100
6200
6300
6400
6500
6600
6700
6800

PRINT TAB(lO); "Bimolecular Inhibition Rate Constant Determination:
'ki'"
LPRINT: LPRINT: LPRINT
LPRINT: LPRINT "Inhibitor Compound: "TAB(40) INHIB$: LPRINT
PRINT: PRINT "Inhibitor Compound: " TAB(40) INHIB$: PRINT
LPRINT "Inhibitor Concentration: "TAB(40) INHIBCONC; "M": LPRINT
PRINT "Inhibitor Concentration: "TAB(40) INHIBCONC; "M": PRINT
LPRINT "Time","ln(AO/At)" TAB(40) "Run #";R: LPRINT
PRINT "Time","ln(AO/At)" TAB(40) "Run #";R: PRINT
FOR C=l TO N-1
LPRINT X(C),Y(C): PRINT X(C),Y(C)
NEXT C
LPRINT: PRINT
LPRINT "Equation for the Line:" TAB(40) "Y= "; SLOPE; " X +
";INTERCEPT
PRINT "Equation for the Line:" TAB(40) "Y= "; SLOPE; " X +
";INTERCEPT
LPRINT: LPRINT "Correlation Coefficient: "TAB(40) CORRELCOEFF:
LPRINT
PRINT: PRINT "Correlation Coefficient: "TAB(40) CORRELCOEFF:
PRINT
LPRINT "Standard Deviation of the Slope: "; TAB(40) STDDEVSLOPE:
LPRINT
PRINT "Standard Deviation of the Slope: "; TAB(40) STDDEVSLOPE:
PRINT
LPRINT "·····························>>>>>"·
.............................
' TAB(40) "ki = " KI
PRINT ":::::::::::::::::::::::::::::>>>>>"; TAB(40) "ki = " KI
LPRINT CHR$(12)
'Epson Printer Form Feed
END

APPENDIX B
SAMPLE DATA AND CALCULATION OF RATE CONSTANTS
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Bimolecular Rate Constant
Sample Data and Calculation of ki according to Eqn. 3 for the inhibition of
RBAChE by (R)-malaoxon (Figure 30, Table 8) are shown.

In(Ac/At)

= [i]kl

[i] = 1.00 x 10-6 M

t (min)

A 1 (Abs412nm /min)

ln(AJA 1)

0

0.1005

-----

3

0.0583

0.544

6

0.0314

1.16

9

0.0187

1.68

12

0.0126

2.07

15

0.0089

2.42

r = 0.993
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Bimolecular Reaction, Dissociation, and Phosphorylation Constants
Sample Data and Calculation of ki, K 0 , and kP according to Eqn. 2 for the
inhibition of RBAChE by (JR,3R)-isomalathion (Figure 32, Table 10).

1/[i]

= (Lit/LilnA)ki - l/K

0

k1

= k/K
p

0

At= 20 min

A 0 = 0.0952 (Abs412 nm /min)

I

ll[i] (M- 1)

A 20 (Abs412nm /min)

At!In(AJA20 )

2.50 x 10-Q

20.0 x 106

0.0703

66.0

5.00 x 10-Q

10.0 x 106

0.0531

34.3

10.0 x 10-Q

5.00 x 106

0.0369

21.1

20.0 x 10-Q

2.50 x 106

0.0198

12.7

40.0 x 10-Q

1.25 x 106

0.0129

10.0

[i] (M)

r = 0.991

K 0 = 5.34 x 10-7 (M)

kp = 0.178
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Spontaneous Reactivation
Sample Data and Calculation of k0 according to Eqn. 4 for the spontaneous
reactivation of RBAChE inhibited by (JR,JR)-isomalathion (Figure 34, Table 12).

In( 1OO/%inhibition) = k0t
%inhibition

= (A

- At)l(A - A 0 )

A = 0.0475 (Abs412 nm /min)
t (min)

At (Abs412 /min)

%inhibition

In( 1OO/%inhibition)

0

0.0077

100.0

0.000

4

0.0093

96.0

0.041

8

0.0123

88.4

0.123

12

0.0145

82.9

0.187

16

0.0164

78.1

0.247

20

0.0170

76.6

0.266

24

0.0198

69.6

0.362

28

0.0207

67.3

0.396

32

0.0214

65.6

0.422

36

0.0217

64.8

0.433

40

0.0227

62.3

0.473

44

0.0262

53.5

0.625

48

0.0236

60.1

0.510

52

0.0243

58.3

0.540

56

0.0202

68.6

0.377

60

0.0217

64.8

0.434

r = 0.990
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Oxime-Mediated Reactivation
Sample Data and Calculation of

koxime

according to Eqn. 4 for the

spontaneous reactivation of RBAChE inhibited by (JR,JR)-isomalathion (Figure 34,
Table 12).

In( 1OO/%inhibition) =

koximet

%inhibition = (A - At)l(A - A 0 )
A = 0.0671 (Abs412run /min)
t (min)

At (Abs412 /min)

%inhibition

ln(l 00/o/oinhibition)

0

0.0084

100.0

0.000

1

0.0127

92.7

0.076

2

0.0146

89.4

0.112

3

0.0177

84.2

0.172

4

0.0203

79.7

0.227

5

0.0222

76.5

0.268

6

0.0240

73.4

0.309

7

0.0276

67.3

0.396

8

0.0293

64.4

0.440

9

0.0299

63.4

0.456

10

0.0324

59.1

0.526

k0 = 0.050.6 (min- 1)

r = 0.997

APPENDIX C
SAMPLE SPECTRA
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(S)-Diethyl malate (36a)
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(S)-0-(Trifluoromethanesulfonyl)-diethyl malate (39a)
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(R)-Malathion (6a)
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(R)-Malaoxon (22a)
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N-(Ethyl prolinyl) S-methyl chlorophosphoramidothiolate (50; Fast Band)

PPM
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N-(Ethyl prolinyl) S-methyl chlorophosphoramidothiolate (50; Slow Band)
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Strychnine-(3R)-isomalathion salt (53a)
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Strychnine-(3R)-isomalathion salt (53b)
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Strychnine-(3R)-isomalathion salt (53c)

163

Strychnine-(3R)-isomalathion salt (53d)

164

Strychnine-0,0,S-trimethylphosphorodithioate Salt (54a)
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Strychnine-0,0,S-trimethylphosphorodithioate Salt (54b)
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(JR,3R)-Isomalathion (12a)
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(1R,3S)-lsomalathion (12b)
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(13CH 3S)-(JRS,3RS)-lsomalathion (12 ')
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